Curriculum Vitae
Ted Warren Reid, Ph.D.
Professor
Office Address:
Texas Tech University Health Sciences Center
Department of Ophthalmology and Visual Sciences
Lubbock, Texas 79430
Telephone (806) 743-2400
EDUCATION:
B.A., Occidental College, Los Angeles
M.S., University of Arizona, Tucson
Ph.D., University of California, Los Angeles
HONORS/AWARDS:
Signa Psi, Science Honor Society
Golden Key National Honor Society
Phi Kappa Phi Honor Society
Research to Prevent Blindness Professorship, Yale University
Fellow, Silliman College, Yale University
Visiting Fellow, Imperial Cancer Research Fund, London, England
Association of Research in Vision and Ophthalmology Silver Fellow
Texas Tech University Chancellor's Council Distinguished
Commercialization Award
DIRECTORSHIPS:
Director of Undergraduate Studies
Molecular Biophysics and Biochemistry
Yale University
1961
1963
1967
1973
1998
1997
1973
1974-79
1980
2010
2013
1975-76
Director of Medical Research
Ophthalmology and Visual Science
Yale University School of Medicine
1978-84
Director of Ophthalmic Research
Ophthalmology Department
University of California, Davis, School of Medicine
1984-91
Director of Ocular Cell Biology
Department of Ophthalmology and Visual Sciences
Texas Tech University Health Sciences Center
1991- Present
Vice Chairman
Department of Ophthalmology and Visual Science
Texas Tech University Health Science Center
1991- Present
Director of Biotechnology Program
Texas Tech University Health Sciences Center
Lubbock Campus
2011-Present
Ted W. Reid, Ph.D.
Rev
2
12-29-14
ACADEMIC APPOINTMENTS
National Institutes of Health Postdoctoral Fellow
University of Colorado, Boulder
1967-70
Assistant Professor
Department of Ophthalmology and Visual Science, and
Department of Molecular Biophysics and Biochemistry
Yale University School of Medicine
1970-75
Associate Professor
Department of Biophysics and Biochemistry
Yale University School of Medicine
1975-79
Associate Professor
Department of Ophthalmology and Visual Science
Yale University School of Medicine
1975-79
Visiting Fellow
Imperial Cancer Research Fund
London, England
1980
Senior Research Scientist
Department of Ophthalmology and Visual Science
Yale University School of Medicine
1981-84
Senior Research Scientist
Division of Oncology
Yale University
1982-84
Visiting Fellow
National Eye Institute
National Institutes of Health
1984
Professor
Department of Ophthalmology and Visual Science
University of California, Davis
1984-90
Professor
Department of Integrated Studies
University of California, Davis
1985-90
Professor
Biological Sciences – Graduate Division
University of California, Davis
1985-90
Professor
Department of Ophthalmology and Visual Sciences
Texas Tech University Health Sciences Center
1990- Present
Ted W. Reid, Ph.D.
Rev
3
12-29-14
Professor - Adjunct
Department of Chemistry and Biochemistry
Texas Tech University
1992- Present
Professor – Associate Member
Southwest Cancer Center
Texas Tech University Health Sciences Center
1997- Present
Professor-Associate Member
Department of Microbiology and Immunology
Texas Tech University Health Sciences Center
2003- Present
Director - Lubbock Campus
Biotechnology Program
Texas Tech University Health Sciences Center
2011-Present
BOARD MEMBERSHIPS
Editorial Board Member
JSM Ophthalmology
2013-Present
Board Member
Western Eye Research Conference (ARVO)
1986-2004
Member of Board
Entrepreneurial Family Business Institute
College of Business Administration
Texas Tech University
1996-2003
Board Member (Affiliate)
Comparative Ophthalmic Research Laboratories
University of Wisconsin, Madison, WI
1996-Present
Guest Editorial Board Member
Investigative Ophthalmology and Visual Science
Bethesda, MD
1998-Pesent
Board Member
Selenium Technologies Inc.
Lubbock, TX
1995-Present
Board Member
PharmaSe Inc.
Lubbock, TX
2000-2011
Board Member
Eburon Organic International, Inc.
Lubbock, TX
2001-Present
Ted W. Reid, Ph.D.
Rev
4
12-29-14
Board Member
Center for the Advancement of Rational Solutions
Lincoln, NB
Board Member
City of Lubbock, Board of Public Health
2002-Present
2009-Present
PROFESSIONAL SOCIETIES:
American Chemical Society
American Society for Cell Biology
American Association for the Advancement of Science
Association for Research in Vision and Ophthalmology
International Neuropeptide Society
International Society for Eye Research
Golden Key National Honor Society
New York Academy of Sciences
Phi Kappa Phi Honor Society
Protein Society
Sigma Xi
Society for Biomaterials
Surfaces in Biomaterials Foundation
Society Offices
Member, Program planning committee – Association for Research In Vision and
Ophthalmology
1989-1992
Member, Surfaces in Biomaterials Foundation Awards and Nomination Comm. 1998-1999
Chairman; South Plains Section of the American Chemical Society
1999-2000
Chairman; Ophthalmology Section of the Society for Biomaterials
2000-2001
Vice President; Sigma Xi, Texas Tech University Chapter
2002-2003
President; Sigma Xi, Texas Tech University Chapter
2010-2011
Ted W. Reid, Ph.D.
Rev
5
12-29-14
BIBLIOGRAPHY:
1. 1963 Steelink, C., Reid, T. and Tollin, G. On the nature of the free-radical moiety in lignin.
J. Amer. Chem. Soc. 85:4048-4049.
2. 1963 Tollin, G., Reid, T. and Steelink, C. Structure of humic acid IV. Electronparamagnetic resonance studies. Biochem. Biophys. Acta 66:444-447.
3. 1967 Reid, T. W. and Fahrney, D. The pepsin catalyzed hydrolysis of sulfite esters. J.
Amer. Chem. Soc. 89:3941-3943.
4. 1967 Reid, T.W., Stein, T.P. and Fahrney, D. The pepsin catalyzed hydrolysis of sulfite
esters. II. Resolution of alkyl phenyl sulfites. J. Amer. Chem. Soc. 89:7125-7126.
5. 1969 Lavine, D., Reid, T.W. and Wilson, I.B. The free energy of hydrolysis of the
phosphoryl-enzyme intermediate in alkaline phosphatase catalyzed reactions.
Biochemistry 8:2374-2380.
6. 1969 Reid, T.W., Pavlic, M., Sullivan, D.J. and Wilson, I.B. The mechanistic significance of
phosphate labeling of alkaline phosphatase. Biochemistry 8:3184-3188.
7. 1970 Froede, H.C., Cowan, J., Reid, T.W. and Wilson, I.B. A rapid sampler for intermediate
speed reactions. Anal. Chem. 42:1204-1210.
8. 1971 Reid, T.W. and Wilson, I.B. Conformational isomers of alkaline phosphatase in the
mechanism of hydrolysis. Biochemistry 10:380-387.
9. 1971 Stein, T.P., Reid, T.W. and Fahrney, D. A useful spectrophotometric rate assay for
pepsin. Anal. Biochem. 41:360-364.
10. 1971 Reid, T.W. and Wilson, I.B. E. coli alkaline phosphatase. In The Enzymes, vol. 4, ed.
P.D. Boyer, pp. 373-415. New York: Academic Press.
11. 1972 Reid, T.W. and Albert, D.M. RNA-dependent DNA-polymerase activity in human
tumors. Biochem. Biophys. Commun. Rep. 46:383-390.
12. 1973 Albert, D.M. and Reid, T.W. RNA-directed DNA-polymerase activity in
retinoblastoma: report of its presence and possible significance. Amer. Acad. Ophth.
Otol. 77:630-640.
13. 1973 Reid, T.W., Darling, T.L., Russell, P. and Albert, D.M. RNA-directed DNApolymerase activity in Greene hamster melanoma. Yale J. Biol. & Med. 46:485-491.
14. 1974 Reid, T.W., Albert, D.M., Rabson, A.S., Russell, P., Craft, J., Chu, E.W., Tralka, T.S.
and Wilcox, J.L. Characteristics of an established cell line of retinoblastoma. J. Natl.
Cancer Inst. 53:347-360.
15. 1974 Reid, T.W. and Russell, P. Recent observations regarding retinoblastoma: II. An
enzyme study of retinoblastoma. Trans. Ophthalmol. Soc. U.K. 94:929-937.
Ted W. Reid, Ph.D.
Rev
6
12-29-14
16. 1975 Craft, J., Albert, D.M. and Reid, T.W. Ultrastructural description of a "cylinder
organelle" in the outer plexiform layer of human retinas. Invest. Ophth. 14:923-927.
17. 1976 Kass, M.A., Reid, T.W., Neufeld, A.H. Bausher, L.P. and Sears, M.L. The effect of disoproterenol on intraocular pressure of the rabbit, monkey and man. Invest. Ophth.
15:113-118.
18. 1976 Albert, D.M., Lahav, M., Bhatt, P.N., Reid, T.W., Ward, R.E., Cykiert, R.C., Lin, T.S.,
Ward, D.C. and Prusoff, W.H. Successful therapy of herpes hominis keratitis in rabbits
by 5-iodo-5'-amino-2'5'-dideoxy-uridine (AIU). A novel analog of thymidine. Invest.
Ophth. 15:470-478.
19. 1976 Reid, T.W., Russell, P. and Albert, D.M. Induction of the release of viral particles from
Greene hamster melanoma cells by thymidine. In Pigment Cell, vol. 2, ed. V. Riley,
pp. 22-30. Basel: S. Karger. (Proceedings of the X International Pigment Cell
Conference, Part II, 1977, Cambridge, MA.)
20. 1977 Darling, T., Albert, J. Russell, P., Albert, D.M. and Reid, T.W. Rapid purification of an
RNA tumor virus and proteins by high-performance steric exclusion chromatography
on porous glass bead columns. J. Chromatography 131:383-390.
21. 1977 Dryja, T.P., Albert, D.M., Rosengren, E. and Reid, T.W. Presence of cysteinyldopa in
the mature bovine eye. Exp. Eye Res. 25:459-464.
22. 1979 Gregerson, D.S. and Reid, T.W. Hamster melanoma virus: a unique retrovirus. In
Pigment Cell, vol. 5, ed. S.N. Klaus, pp. 129-135. Basel: S. Karger. (Proceedings of
the X International Pigment Cell Conference, Part II, 1977, Cambridge, MA.)
23. 1979 Darling, T.L. and Reid, T.W. Apparent allosterism by avian myeloblastosis virus
reverse transcriptase and E. coli DNA polymerase I. Nucl. Acids Res. 6:1189-1202.
24. 1979 Gregerson, D.S., Russell, P. and Reid, T.W. Biochemical and immunological
properties of the reverse transcriptase associated with a hamster retrovirus. J. Gen.
Virol. 43:327-337.
25. 1979 Russell, P., Gregerson, D.S., Albert, D.M. and Reid, T.W. Characteristics of a
retrovirus associated with a hamster melanoma. J. Gen. Virol. 43:317-326.
26. 1980 Gregerson, D.S., Albert, J. and Reid, T.W. Processive nature of reverse transcription
by avian myeloblastosis virus deoxyribonucleic acid polymerase. Biochemistry
19:301-306.
27. 1980 Gregerson, D.S. and Reid, T.W. Properties of the reverse transcription of synthetic and
hamster retroviral RNA by avian and hamster viral polymerases. Biochem. & Biophys.
Res. Comm. 93:720-728.
28. 1980 Ljunggren, B., Carter, D.M., Albert, J. and Reid, T.W. Plasma levels of 8methoxypsoralen determined by high-pressure liquid chromatography in psoriatic
patients ingesting drug from two manufacturers. J. Invest. Dermatology 74:59-62.
Ted W. Reid, Ph.D.
Rev
7
12-29-14
29. 1981 Gilbert, F., Balaban, G., Breg, W.R., Gallie, B., Reid, T. and Nichols, W.
Homogeneously staining region in a retinoblastoma cell line: relevance to tumor
initiation and progression. J. Natl. Cancer Institute 67:301-306.
30. 1981 Pahuja, S.L, Albert, J. and Reid, T.W. Use of reversed-phase high-performance liquid
chromatography for simultaneous determination of glutamine synthetase and glutamic
acid decarboxylase in crude extracts. J. Chrom. 225:37-45.
31. 1981 Rubin, N.A., Tarsio, J.F., Borthwick, A.C., Gregerson, D.S. and Reid, T.W.
Identification and characterization of a growth factor secreted by an established cell
line of human retinoblastoma maintained in serum-free medium. Vision Res.
21:105-112.
32. 1982 Pahuja, S.L. and Reid, T.W. Radioisotope assay for glutamine synthetase using thinlayer chromatography. J. Chrom. 235:249-255.
33. 1983 Pahuja, S.L. and Reid, T.W. A simple microassay for glutamic acid decarboxylase by
ion exchange thin-layer chromatography. J. Liquid Chromat. 6(1): 127-137.
34. 1983 Pahuja, S.L. and Reid, T.W. Thin-layer chromatographic determination of Lasparaginase in the presence of human serum. J. Chrom. 273:431-435.
35. 1983 Tarsio, J.F., Rubin, N.A., Russell, P., Gregerson, D.S. and Reid, T.W. Growth
stimulatory effects of retinoblastoma derived growth factors and other mitogens in
Nakano mouse lens epithelial cells. Exp. Cell Res. 146:71-78.
36. 1984 Jones, T.R. and Reid, T.W. Trace elements in the eye. In Handbook of Experimental
Pharmacology, ed. M.L. Sears, pp. 667-685. Berlin:
Springer-Verlag.
37. 1984 Jones, T.R. and Reid, T.W. Sodium orthovanadate stimulation of DNA synthesis in
Nakano mouse lens epithelial cells in serum-free medium. J. Cellular Physiology
121:199-205.
38. 1984 Pahuja, S.L., Albert, J. and Reid, T.W. Use of an optimum wavelength to detect
glutamic acid and its metabolites in human serum by reversed phase HPLC. J. Liquid
Chromatogr. 7:2261.
39. 1985 Pahuja, S.L., Mullins, B.T. and Reid, T.W. Bovine retinal glutamine synthetase 1.
Purification characterization and immunological properties. Exp. Eye Res. 40:61-74.
40. 1985 Pahuja, S.L. and Reid, T.W. Bovine retinal glutamine synthetase 2. Regulation and
properties on the basis of glutamine synthetase and glutamyl transferase reactions.
Exp. Eye Res. 40:75-83.
41. 1986 Jones, T.R., Antonetti, D.L. and Reid, T.W. Aluminum ions stimulate mitosis in
murine cells in tissue culture. J. Cellular Biochemistry 30:31-39.
42. 1986 Potluri, V.R., Helson, L., Ellsworth, R.M., Reid, T.W. and Gilbert, F. Chromosomal
abnormalities in human retinoblastoma - a review. Cancer
Ted W. Reid, Ph.D.
Rev
8
12-29-14
58:663-671.
43. 1986 Pansky, B., Das, A., Budd, G.C. and Reid, T.W. Insulin-like immunoreactivity in
human retinoblastoma Y79 cell-line. Neurosci. L. 68:187-191.
44. 1987 Gentleman, S., Reid, T.W. and Martensen, T.M. Vanadate stimulation of
phosphotyrosine protein levels in quiescent Nakano mouse lens cells. Exp. Eye Res.
44:587-594.
45. 1987 Reid, T.W. and Reid, W.A. The labile nature of the insulin signal(s) for the stimulation
of DNA synthesis in mouse lens epithelial and 3T3 cells. J. Biol. Chem. 262:229-233.
46. 1987 Russell, P., Zelenka, P., Martensen, T. and Reid, T.W. Identification of the EDTAextractable protein in lenses as calpactin I. Current Eye Res. 6:533-538.
47. 1990 Cullor, J.S., Mannis, M.J., Murphy, C.J., Smith, W.L., Selsted, M.E. and Reid, T.W. In
vitro antimicrobial activity of defensins against ocular pathogens. Arch. Ophthalmol.
108:861-864.
48.
1991 Das, A., Pansky, B., Budd, G.C. and Reid, T.W. Human retinoblastoma Y79 cells
contain both insulin-specific mRNA and insulin-binding sites. Neurosci. L. 121:231-3.
49.
1992 Schwab, I.R., Dries, D., Cullor, J.S., Smith, W.L., Mannis, M.J., Reid, T.W. and
Murphy, C. Corneal storage medium preservation with defensins. Cornea 11:370-375.
50.
1993 Murphy, C.J., Foster, B.A., Mannis, M.J., Selsted, M. and Reid, T.W. Defensins are
mitogenic for epithelial cells and fibroblasts. J. Cellular Phys. 155:408-413.
51.
1993 Reid, T.W., Murphy, C.J., Iwahashi, C.K., Foster, B.A. and Mannis, M.J. The
stimulation of epithelial cell growth by the neuropeptide Substance P. J. Cellular
Biochem. 52:476-485.
52.
1994 Villablanca, A., Murphy, C. and Reid, T.W. Growth-Promoting Effects of Substance P
on Endothelial Cells in Vitro. Circulation Research. 75(6): 1113-1120.
53.
1994 Reid, T.W. Growth control of cornea and lens epithelial cells. Progress in Retinal and
Eye Research, 13(2): 507-554.
54.
1994 Dushku, N. and Reid, T.W. Immunohistochemical Evidence that Pterygia Arise From
Altered Limbal Epithelial Basal Stem Cells. Current Eye Research 13: 473-481.
55.
1995 Birney, D.M., Cole D.C., Crosson, C.E., Kahl, B.F., Neff, B.W., Reid, T.W., Ren, K.
and Walkup, R.D. The Use of -Methylphenylalanine (MeF) Residues to Probe the
Nature of the Interaction of Substance P With its Receptor: Effects of MeF-Containing
Substance P Analogs on Rabbit Iris Smooth Muscle Contraction J. Med. Chem. 38:
2478-2482.
56.
1995 Kahl, B. and Reid, T.W. Substance P and the Eye. Progress in Retinal and Eye
Research, 14(2): 473-504.
Ted W. Reid, Ph.D.
9
Rev
12-29-14
57.
1996 Reid, T.W. and Dushku, N. Pterygia and Limbal Epithelial Cells: Relationship and
Molecular Mechanisms. Progress in Retinal and Eye Research, 15(2): 297-329.
58.
1996 Nishida, T., Nakamura, M., Ofuji, K., Reid, T.W., Mannis, M. and Murphy, C.J.
Synergistic Effects of Substance P with Insulin-Like Growth Factor on Epithelial
Migration of the Cornea. J. Cellular Physiology 169:159-166.
59.
1997 Brown, S., Lamberts, D. Reid, T., Nishida, T., Murphy, C. Neurotrophic and Anhidrotic
Keratopathy Treated with Substance P and Insulin Like Growth Factor, Archives
Ophthalmology 115: 926-927.
60.
1997 Nakamura, M., Nishida, T., Ofuji, K., Reid, T.W., Mannis, M.J. and Murphy, C.J.
Synergistic Effects of Substance P with Epidermal Growth Factor on Epithelial
Migration in Rabbit Cornea, Exp. Eye Res. 65:321-329.
61.
1997 Villablanca, A.C. and Reid, T.W. Substance P Stimulates Vascular Endothelial Cellular
Reducing Capacity in the Presence of Insulin and Human Plasma Factors, J. Cellular
Biochemistry 66:471-481.
62.
1997 Dushku, N. and Reid, T.W. P53 Expression in Altered Basal Cells of Pingueculae,
Pterygia, and Limbal Tumors, Current Eye Research 16: 1179-1192.
63.
1997 Nishida, T., Nakamura, M., Konma T., Ofuji, K., Nagano, K., Tanaka, T., Enoki, M.,
Reid, T.W., Brown, S.M., Murphy, C.J., Mannis, M.J. Neurotrophic keratopathy studies on substance P and the clinical significance of corneal sensation. Nippon Ganka
Gakkai Zasshi 101:948-974.
64.
1998 Spallholz, J., Reid, T.W., Boylan, M., Shriver, B. Selenium Free Radical Chemistry:
Applications for Pharmaceuticals, STDA Sixth International Symposium 6: 47-56.
65.
1998 McDermott, A.M., Kern, T.S., Reid, T.W., Russell, P. and Murphy, C.J. Effect of
substance P, insulin-like growth factor-1 and vasoactive intestinal polypeptide on
corneal re-epithelialization I galactosemic rats. Curr. Eye Res. 17:1143-1149.
66.
1999 Dushku, N., Hatcher, S., Albert, D., and Reid, T.W. P53 expression and relation to
human papillomavirus infection in pingueculae, pterygia, and limbal tumors. Arch.
Ophth. 117:1593-1599.
67.
1999 Reid, T.W., Opolski, M.P. and Spallholz, J.E. Organo-Selenium Molecules CovalentlyAttached to a Surface Block Biofilm Formation. SurFACTS 4(2): 6-7.
68.
2001 Dushku, N., Molykutty, K, Schultz, G. and Reid, T.W. Pterygia pathogenesis: Corneal
invasion by MMP Expressing altered limbal epithelial basal cells. Arch. Ophth.
119:695-706.
69.
2001 Bentley E, Abrams GA, Covitz D, Cook CS, Fischer CA, Hacker D, Stuhr CM, Reid
TW, Murphy CJ. Morphology and Immunohistochemistry of Spontaneous Chronic
Corneal Epithelial Defects (SCCED) in Dogs. Invest Ophthalmol Vis Sci. 42;22622269.
Ted W. Reid, Ph.D.
10
Rev
12-29-14
70.
2001 Murphy CJ, Marfurt CF, McDermott A, Bentley E, Abrams GA, Reid TW, Campbell S.
Spontaneous Chronic Corneal Epithelial Defects (SCCED) in Dogs: Clinical Features,
Innervation, and Effect of Topical SP, with or without IGF-1. Invest Ophthalmol Vis
Sci. 42:2252-61.
71.
2001 Spallholz, J.E., Shriver, B.J., Reid, T.W. Dimethyldiselenide and methylseleninic acid
generate Superoxide in an in vitro chemiluminescence assay in the presence of
glutathione: implications for the anticarcinogenic activity of L-selenomethionine and LSe-methylselenocysteine. Nutr. Cancer 40:34-41.
72.
2002 Lee, C.H., Whiteman, A.L., Murphy, C.J., Barney, N.P., Taylor, P.B. and Reid, T.W.
Substance P, insulin-like growth factor I and surface healing. Arch Ophthalmol.
120:215-217.
73.
2002 Dushku, N., Molykutty, K, Schultz, G. and Reid, T.W. Republication of color figures:
Pterygia pathogenesis: Corneal invasion by MMP Expressing altered limbal epithelial
basal cells. Arch. Ophth. 120:234-237.
74.
2002 McAnulty JF, Reid TW, Waller KR, and Murphy CJ. Successful six-day kidney
preservation using trophic factor supplemented media and simple cold storage.
Am J Transplant. 2(8):712-8.
75.
2003 Reid, TW and Dushku, N. Does human papillomavirus cause pterygium?
Br J Ophthalmol 87: 806-808
76.
2003 Reid, T.W., Tran, P., Spallholz, J. and Fralick, J. Counter Terrorism Measures to
Combat Yersinia Pestis with Selenium Pharmaceuticals. Proceedings of the 2002 Joint
Service Scientific Conference on Chemical and Biological Defense Research. 2003, 17.
77.
2004 Spallholz, J.D., Palace, V.P. and Reid, T.W. Methioninase and selenomethionine but
not Se-methylselenocysteine generate methylselenol and superoxide in an in vitro
chemiluminescent assay: implications for the nutritional carcinostatic activity of
selenoamino acids. Biochemical Pharmacology 67:547-554.
78.
2004 McAnulty JF, Foley JD, Reid TW, Heath TD, Waller KR, Murphy CJ. Suppression
of cold ischemic injury in stored kidneys by the antimicrobial peptide bactenecin.
Cryobiology;49(3):230-40.
79.
2004 Brown SM, Khanani AM, Stetson CL, Reid TW. Vesicular eruption in a child with
trigeminal nerve palsy during topical therapy with substance P and insulin-like
growth factor I for neurotrophic keratitis. Arch Ophthalmol. 2004
Nov;122(11):1722-3
80.
2005 Murray, B.E., Anderson, K.E. Arnold, K., Bartlett, J.G., Carpenter, C.C., Falkow, S.,
Hartman, J.T. Lehman, T., Reid, T.W., Ryburn, Jr., F.M., Sack, R.B., Struelens, M.J.,
Young, L.S., and Greenough III, W.B,, Destroying the Life and Career of a Valued
Physician-Scientist Who Tried to Protect Us from Plague: Was It Really Necessary ?
Clin Infect Dis 40:1644-1648
Ted W. Reid, Ph.D.
11
Rev
12-29-14
81.
2006 Schneider, B.G., John-Aryankalayil, M., Rowsey, J.J., Dushku, N., and Reid, T.
Accumulation of p53 protein in pterygia is not accompanied by TP53 gene mutation.
Exper. Eye Research 82: 91-98
82.
2006
John-Aryankalayil, M., Dushku, N., Jaworski, C., Cox, C., Schultz, G., Smith, J., Keri
R., Dietrich S., Reid T., "Carper, D., Microarray and protein analysis of human
pterygium. Mol Vis 12: 55-64.
83. 2006
McDermott, A.M., Rich, D., Cullor, J., Mannis, M., Smith, W., Reid, T.W., Murphy,
C.J., “The in vitro activity of selected defensins against an isolate of Pseudomonas in
the presence of human tears.” British J. Ophthalmology 90:609-611.
84. 2006
Mathews, S.M., Spallholz, J.E., Grimson, M.J., Dubielzig, R.R., Gray, T., Reid, T.W
Prevention of bacterial colonization of contact lenses with covalently attached selenium
and effects on the rabbit cornea. Cornea. 25:806-14.
85. 2007
Schneider, B.G., Sahni, D., Torres, J.C., Dushku, N., Reid, T.W. MLH1 and
MSH2 Expression in Pterygia. Cornea 26:468-72.
86. 2008 Low, T., Jackson, A., Morse, A., Mosley, T., Reid, T.W., Selenium Coating of
Water Distribution Tubing to Inhibit Biofilm, SAE International
http://papers.sae.org/2008-01-2158
87. 2009
Tran, P.L., Hammond, A.A., Mosley, T., Janette Cortez, J., Gray, T., ColmerHamood, J.A., Shashtri, M., Spallholz, J.E., Hamood, A.N. and Reid, T.W. An
Organo-Selenium Coating on Cellulose Inhibits Pseudomonas aeruginosa and
Staphylococcus aureus Biofilm Formation. Applied and Environmental
Microbiology 75: 3586-3592.
88. 2009
Pot, S.A., Chandler, H.L., Colitz, C.M., Bentley, E., Dubielzig, R.R., Mosley, T.W.,
Reid, T.W., & Murphy, C.J. Selenium functionalized intraocular lenses inhibit
posterior capsule opacification in an ex vivo canine lens capsular bag assay.
Experimental Eye Research. 89: 728-234.
89. 2009
Jaworski, C., Aryankalayil-John, M., Campos, M., Fariss, R. Rowsey, J., Agarwalla,
N., Reid, T.W., Dushku, N., Cox, C., Carper, D., Wistow, G. Expression analysis of
conjunctival and limbal markers and genes associated with cell migration. Mol. Vis.
20: 2421-34.
90. 2010
Reid, T., Tran, P., Cortez, J., Mosley, T., Shashtri, M., Spallholz, J., Pot, S. and
Hamood., A. Medical Devices Coated with Organo-Selenium Inhibit Bacterial and
Cellular Attachment. International Medical Devices 5: 23-31.
91. 2010
Bradley, J.C., Yang, W., Bradley, R.H., Reid, T.W., Schwab, I.R., The Science of
Pterygia, Br J Ophthalmol 94:815-820
92. 2010
Cox CA, Amaral J, Salloum R, Guedez L, Reid TW, Jaworski C, John-Aryankalayil M,
Freedman KA, Campos MM, Martinez A, P Becerra S, Carper DA. Doxycyclin’s
Ted W. Reid, Ph.D.
Rev
12
12-29-14
Effect on Ocular Angiogenesis: An In Vivo Analysis. Ophthalmology. 117(9):178291.
93. 2010
Reid, T. and Dushku, N. What a study of pterygia teaches us about the cornea?
Molecular mechanism of formation. Eye Contact Lens. 36:290-5.
94. 2011
Reid, T., Tran, P., Mosley, T., Tran ,K Jarvis,C. Patel S., Shashtri, M., Haynes, R.,
and Hamood., A. Biopolymers Containing Selenium: Their Synthesis and Use.
International Journal Medical Devices Vol 6, No.2
95. 2011
Low, D., Hamood, A., Reid, T.W., Mosley, T., Tran, P., Song, L. and Morse, A.
Attachment of selenium to a reverse osmosis membrane in inhibit biofilm formation of
S. aureus. J. Membrane Science 378:171-178.
96. 2011
Toris, C.B., Gulati, V, Reid, T.W. and Quigley, H. Reflections on the career of Carl
Camras. Expt. Eye Resch. 2011: 1-4.
97. 2011
Yang, W., Bradley, J.C. Reid, T.W. and McCartney, D. L. Growth factors in aqueous
humor. Ophthalmology 118:1003-1003.
98. 2012
Tran, T., Lowry, N., Campbell, T., Reid, T. W., Webster, D., Tobin, E., Aslani, A.,
Mosley, T., Dertien, J., Colmer-Hamood, J., and Hamood, A. An Organoselenium
Compound Inhibits Staphylococcus aureus Biofilms on Hemodialysis Catheters in
Vivo. Antimicrobial Agents and Chemotherapy 56:972-978.
99. 2013
Vercellino, T, Morse, A, Tran, P, Song, L, Hamood, A, Reid, T, Moseley, T.
Attachment of organo-selenium to polyamide composite reverse osmosis membranes to
inhibit biofilm formation of S. aureus and E. coli. Desalination 309:291-295.
100. 2013 Tran P, Hamood A, Mosley T, Gray T, Jarvis C, Webster D. Amaechi B, Enos T, Reid
T. Organo-Selenium-containing Dental Sealant Inhibits Bacterial Biofilm. J. Dental
Research 92: 461-466.
101. 2013 Vercellino T, Morse A, Tran P, Song L, Hamood A, Reid T, et al. Inhibition of S.
aureus and E.coli biofilm formation in reverse osmosis systems using an organoselenium surface treatment. Desalination. Manuscript accepted, DES-D-12-01338R1.
102. 2013 Wang JC, Tran PL, Hanes R, Cordero J, Marchbanks J, Reid TW, Colmer-Hamood JA,
Hamood AN. Inhibition of Otopathogenic Biofilms by Organoselenium-coated
Tympanostomy Tubes. JAMA Otolaryngol Head Neck Surg. 139:1009-16.
103. 2013 Vercellino T, Morse A, Tran P, Hamood A, Reid T, Song L, Moseley T. The Use of
Covalently Attached Organo-Selenium to Inhibit S. aureus and E. coli Biofioms on RO
Membranes and Feed Spacers. Desalination 317:142-151.
104. 2013 Vercellino T, Tran P, Reid T, Hamood A, Morse A. Evaluation of polymerized organoselenium feed spacers to inhibit S. aureus and E. coli biofilm development in reverse
osmosis systems. Desalination 331: 1-5.
Ted W. Reid, Ph.D.
Rev
13
12-29-14
105. 2014 Tran P, Hamood A and Reid, T. Antimicrobial coatings to prevent biofilm formation
on medical devices. Antibiofilm Agents: From Diagnosis to Treatment and Prevention,
Springer Series on Biofilms, Vol 8, (Rumbaugh and Ahmad Eds), 2014, pp175-204.
106. 2014 Tran P, Patel S, Hamood A, Enos T, Mosley T, Jarvis C, Akash D, Lin P, Reid TW. A
novel organo-selenium bandage that inhibits biofilm development in a wound by Grampositive and Gram-negative wound pathogens. Antibiotics 3: 435-449.
107. 2014 Tran P, Hamood A, de Souza A, Schultz G, Liesenfeld B, Mehta D, Reid TW. A study
on the ability of quaternary ammonium groups attached to a polyurethane foam wound
dressing to inhibit bacterial attachment and biofilm formation. Wound Rep Reg
DOI: 10.1111/wrr.12244
Ted W. Reid, Ph.D.
Rev
14
12-29-14
SUBMITTED:
Zhang, Z, Penturf, M, Reid, T.W., Boylan, M., Spallholz, J., Griswald, J. The effect of Topical
Application of Substance P or Selenocystamine on the Healing of Full Thickness Punch
Wounds in the Rat. (resubmitted) Wound Healing
Kahl, B., Saban, R., Murphy, C., Bjorling, D., Birney, D., Walkup, R., and Reid, T.W., Methylphenylalanine analogs of substance P: Indication of different functional subtypes of the
NK-1 receptor (resubmitted). Peptides
Iwahashi, C. K., Pahuja, S. and Reid T. W. The effect of dexamethasone on DNA Synthesis in
dependent upon cell type and growth factor. (Submitted) J. Cellular Physiology
Reid, T. W. and Hamill, V. The role of prostaglandins and leukotrienes as late signals for
growth factor stimulation of DNA synthesis. (Submitted) J. Cellular Biochemistry.
Dushku, N. and Reid, T.W. Abnormal H-ras suppression and activation in
the altered limbal basal cells (Pterygium Cells) of pterygia. (Submitted) Molecular
Vision
Ted W. Reid, Ph.D.
Rev
15
12-29-14
TEXTS:
1. 1971 Reid, T.W. and Wilson, I.B. E. coli alkaline phosphatase. In The Enzymes, vol. 4, pp.
373-415, ed. P.D. Boyer. New York: Academic Press.
2. 1976 Reid, T.W., Russell, P. and Albert, D.M. Induction of the release of viral particles from
Greene hamster melanoma cell by thymidine. In Pigment Cell, vol. 2, ed. V. Riley, pp.
22-30. Basel: S. Karger. (Proceedings of IX International Pigment Cell Conference.)
3. 1979 Gregerson, D.S. and Reid, T.W. Hamster melanoma virus: a unique retrovirus. In
Pigment Cell, vol. 5, ed. S.N. Klaus, pp. 129-135. Basel: S. Karger. (Proceedings of
the X International Pigment Cell Conference, Part II, Cambridge, MA, 1977.)
4. 1984 Jones, T.R. and Reid, T.W. Trace elements in the eye. In Pharmacology of the Eye,
vol. 69, ed. M.L. Sears, pp. 667. Berlin: Springer-Verlag.
5. 1994 Reid, T.W. Growth control of cornea and lens epithelial cells. In Progress in Retinal
and Eye Research, vol. 13(2). 507-554. Osborne and Chader eds. Great Britain:
Elsevier Science.
6.
1995 Kahl, B. and Reid, T.W. Substance P and the Eye. Progress in Retinal and Eye
Research, 14(2): 473-504. Osborne and Chader eds. Great Britain: Elsevier Science.
7.
1996 Reid, T.W. and Dushku, N. Pterygia and Limbal Epithelial Cells: Relationship and
Molecular Mechanisms. Progress in Retinal and Eye Research, 15(2): 297-329.
8.
2014 Tran, P, Hamood, A, and Reid T.W. Antimicrobial coatings to prevent biofilm
formation on medical devices. In Antibiofilm Agents: From Diagnosis to Treatment
and Prevention. Springer Series on Biofilms, Vol. 8 Rumbaugh and Ahmad (Eds),
2014, pp175-204.
Ted W. Reid, Ph.D.
Rev
16
12-29-14
ABSTRACTS:
1.
Albert, D. M. and Reid, T. RNA-Dependent DNA-Polymerase in Retinoblastoma and
Related Tumors. ARVO Conference, April 1972, Sarasota, Florida
2.
Berger, R.O., Reid, T.W., Neufeld, A.H. and Sears, M.L. The Effects of Adrenergic Agents
and Prostaglandins on an Isolated Iris Preparation. ARVO Conference, April 1973,
Sarasota, Florida
3.
Reid, T.W., Russell, P. and Albert, D.M. Biochemical Characteristic of an Established Cell
Line of Retinoblastoma. ARVO Conference, April 1974, Sarasota, Florida
4.
Albert, D.M., Reid, T.W., Rabson, A.S. and Chu, E.W. Morphologic and Cytogenetic
Characteristics of an Established Cell Line of Retinoblastoma. ARVO Conference, April
1974, Sarasota, Florida
5.
Lahav, M., Albert, D.M., Reid, T.W., Colby, E. and Shadduck, J. Ocular Neoplasia and
Dysplasia Induced by Feline Sarcoma Virus. ARVO Conference, April 1975, Sarasota,
Florida
6.
Albert, D., Craft, J., DeLellis, R. and Reid, T. Neurosecretory Granules in a Retinoblastoma.
ARVO Conference, April 1975, Sarasota, Florida
7.
Albert, D., Lahav, M., Bhatt, P., Reid, T., Ward, D. and Prusoff, W. Successful Therapy of
Herpes Virus Hominis Keratitis in Rabbits by 5'-Amino-2', 5'-Deoxy-5-Iodouridine (AIU).
ARVO Conference, April 1975, Sarasota, Florida
8.
Reid, T.W. and Albert, D.M. A Substrate Study of Glutamine Transferase from the Retina.
ARVO Conference, April 1975, Sarasota, Florida
9.
Albert, D.M., Gallie, B., Reid, T.W., Ryu, S. and Schwartz, E. Heterologous Transplantation
of Ocular Melanomas and Retinoblastomas. ARVO Conference, April 1976, Sarasota,
Florida
10.
Reid, T.W., Dryja, T. and Albert, D.M. The Determination off 5-S-Cysteinyldopa Levels in
the Eye. ARVO Conference, April 1976, Sarasota, Florida
11.
Gregerson, D.S. and Reid, T.W. Type C-Like Virus Particle from Human Retinoblastoma
Cells. ARVO Conference, April 1977, Sarasota, Florida
12.
Pahuja, S. and Reid, T. Characteristics and Induction of Glutamine Synthetase in Retinal
Cells. ARVO Conference, April 1978, Sarasota, Florida
13.
Pahuja, S.L., Mullins, B.T. and Reid, T.W. Characterizations of Glutamine Synthetase from
the Retina. ARVO Conference, April 1979, Sarasota, Florida
14.
Rubin, N., Lee, M. -S., Gregerson, D.S. and Reid, T.W. Growth of a Retinal Tumor Cell
Line in Tissue Culture without Serum. ARVO Conference, April 1979, Sarasota, Florida.
Ted W. Reid, Ph.D.
Rev
17
12-29-14
15.
Rubin, N.A., Borthwick, A.C., Albert, J., Gregerson, D.S. and Reid, T.W. Identification and
Characterization of a Mitogenic Factor Secreted by an Established Cell Line of Human
Retinoblastoma Maintained in Serum-Free Media. American Society for Cell Biology,
November 1979, Toronto, Canada
16.
Pahuja, S.L., Mullins, B.T. and Reid, T.W. A Comparison of Molecular and Kinetic
Characteristics of Glutamine Synthetase from Brain Cells and Retinal Cells. American
Society for Cell Biology, November 1979, Toronto, Canada
17.
Pahuja, S.L. and Reid, T.W. A New Radioactive Method for Studying Kinetics of Retinal
Glutamine Synthetase. ARVO Conference, May 1980, Orlando, Florida
18.
Tarsio, J.F., Gregerson, D.S., Russell, P. and Reid, T.W. Secretion of a Growth Promoting
Activity for Nakano Mouse Lens Epithelial Cells by a Human Retinoblastoma Cell Line.
ARVO Conference, May 1980, Orlando, Florida
19.
Rubin, N.A., Gregerson, D.S. and Reid, T.W. Retinoblastoma-derived Growth Factor
(RDGF), a Mitogenic Factor Secreted by an Established Human Retinoblastoma Cell Line
(Y-79). ARVO Conference, May 1980, Orlando, Florida
20.
Rubin, N.A., Gregerson, D.S. and Reid, T.W. Identification and Characterization of a
Growth Factor (RDGF) Secreted by an Established Cell Line of Human Retinoblastoma
Cells (Y-79). Fifth SOVD, June 9-10, Temple University, Philadelphia, Pennsylvania
21.
Tarsio, J.F., Gregerson, D.S., Russell, P. and Reid, T.W. Secretion of a Growth Promoting
Activity for Nakano Mouse Lens Epithelial Cells by a Human Retinoblastoma Cell Line.
Fifth SOVD, June 9-10, 1980, Temple University, Philadelphia, Pennsylvania
22.
Tarsio, J.F., Rubin, N.A., Gregerson, D.S., Russell, P. and Reid, T.W. Secretion of a Growth
Promoting Activity for Nakano Mouse Lens Epithelial Cells by a Human Retinoblastoma
Cell Line. American Society for Cell Biology, November 14-18, 1980, Cincinnati, Ohio
23.
Rubin, N.A., Tarsio, J.F., Gregerson, D.S. and Reid, T.W. Identification and
Characterization of a Growth Factor Secreted by an Established Cell Line (Y-79) of
Human Retinoblastoma Maintained in Serum-Free Medium. American Society for Cell
Biology, November 14-18, 1980, Cincinnati, Ohio
24.
Pahuja, S.L. and Reid, T.W. A simple and Sensitive Method for Asparaginase. American
Society for Cell Biology, November 14-18, 1980, Cincinnati, Ohio
25.
Pahuja, S.L., Mullins, B.T., Lee, M.S. and Reid, T.W. Regulation of Glutamine Synthetase
by Insulin and Glutamine in Retinal Tumor Cells. American Society for Cell Biology,
November 14-18, 1980, Cincinnati, Ohio
26.
Tarsio, J.F., Poirier, D.L., Gregerson, D.S. and Reid, T.W. Effect of Retinoblastoma Derived
Growth Factor and Other Mitogens on the Growth of Lens and 3T3 Cells in Culture.
ARVO Conference, April 27 to May 1, 1981, Sarasota, Florida
27.
Czako-Herskovic, M., Golde, W., Stein, P.J., Sorbi, R.T., Pahuja, S.L. and Reid, T.W. Role
of the Retinal Rod Outer Segment Membrane in the Biosynthesis of Rhodopsin: A
Ted W. Reid, Ph.D.
Rev
18
12-29-14
Monoclonal Antibody Approach. American Society for Cell Biology, November 9-13,
1981, Anaheim, California
28.
Reid, T.W. and Antonetti, D.L. Characteristics of a Human Retinoblastoma Cell Line
Growing Totally Serum Free: Effects of the Addition of Other Factors. ARVO
Conference, May 2-7, 1982, Sarasota, Florida
29.
Reid, T.W., Pahuja, S.L., Albert, J. and Mullins, B.T. Purification and Characterization off
Retinoblastoma Derived Growth Factor Based upon Its Self-Association. American
Society for Cell Biology, November 30, 1982, Baltimore, Maryland
30.
Jones, T.R. and Reid, T.W. DNA Synthesis in Cultured Lens Cells by Ortho Vanadate.
ARVO, May 1, 1983, Sarasota, Florida
31.
Pahuja, S.L. and Reid, T.W. Multiple Molecular Forms and Properties of Purified
Retinoblastoma Derived Growth Factor. ARVO, May 1, 1983, Sarasota, Florida
32.
Reid, T.W. and Pahuja, S.L. Mechanisms of Action of Retinoblastoma Derived Growth
Factor on Lens Epithelial Cells - Role of Aggregation. American Society for Cell
Biology, November 29, 1983, San Antonio, Texas
33.
Reid, T.W. and Pahuja, S.L. Cell Surface Aggregation of Retinoblastoma Derived Growth
Factor (RDGF) on Lens Epithelial Cells. ARVO, April 29, 1984, Sarasota, Florida
34.
Pahuja, S.L. and Reid, T.W. Synergism between Insulin and Retinoblastoma Derived
Growth Factor for the Stimulation of DNA Synthesis in Lens Epithelial Cells. ARVO,
April 29, 1984, Sarasota, Florida
35.
Graupner, G.A., Bialasiewicz, A.A., Salowski, A.B. and Reid, T.W. Lectin Binding Patterns
of Human Retinoblastoma Cell Lines and Retinal Pigment Epithelial Cells. ARVO, April
29, 1984, Sarasota, Florida
36.
Jones, T.R., Antonetti, D.L. and Reid, T.W. Aluminum Induces Mitosis in Nakano Mouse
Lens Epithelial Cells. ARVO, April 29, 1984, Sarasota, Florida
37.
Lee, M.S. and Reid, T.W. DNA-Mediated Transfer of Retinoblastoma Genes into Mouse L
Cells. ARVO, April 29, 1984, Sarasota, Florida
38.
Gentleman, S. and Reid, T.W. Vanadate Enhances Phosphotyrosine Protein Levels in
Nakano Lens Cells. Federation of American Societies for Experimental Biology, April 21,
1985, Anaheim, California
39.
Lee, M.S., Dryja, T.P., Albert, D.M. and Reid, T.W. Retinoblastoma Derived Growth Factor
Is Not A N-Myc Gene Product. ARVO, May 8, 1985, Sarasota, Florida
40.
Reid, T.W. and Pahuja, S. Protection Against the Effects of Dexamethasone on Murine Lens
Epithelial Cells by Transient Exposure to RDGF. ARVO, May 8, 1985, Sarasota, Florida
41.
Reid, T.W. The Transient Nature of the Insulin Second Messenger. UCLA Molecular
Biology Symposium, April 6, 1986, Steamboat Springs, Colorado
Ted W. Reid, Ph.D.
Rev
19
12-29-14
42.
Lee, M.S., Albert, D.M. and Reid, T.W. A New Protein Induced by Retinoblastoma Derived
Growth Factor. ARVO, April 28, 1986, Sarasota, Florida
43.
Reid, T.W. and Reid, W.A. The Insulin Second Messenger for the Stimulation of DNA
Synthesis in Lens Epithelial Cells. ARVO, April 28, 1986, Sarasota, Florida
44.
Reid, T.W., Gentleman, S., Martensen, T. and Kon, H. Vanadate and Insulin Synergism in
the Stimulation of DNA Synthesis and Tyrosine Phosphorylation. American Society of
Cell Biology and American Chemical Society, June 9, 1986, Washington, D.C.
45.
Lee, M.S., McGee, T. and Reid, T.W. Transfer of Retinoblastoma Derived Growth Factor
Gene to Mouse L Cells. ARVO, May 4-8, 1987, Sarasota, Florida
46.
Reid, T.W. and Hamill, V. Leukotrienes' Roles as Late Signals for Growth Factor
Stimulation of DNA Synthesis. ARVO, May 4-8, 1987, Sarasota, Florida
47.
Reid, T.W. and Lee, R. Aluminum Effects on Mitosis in Lens Epithelial Cells Occur After
Cells Leave G1/G0. ARVO, May 2-6, 1988, Sarasota, Florida
48.
Reid, T.W. and Foster, B. Factors Which Influence the Growth of Retinoblastoma Cells (Y79) in Culture. 8th International Congress of Eye Research, September 40-8, 1988, San
Francisco, California
49.
Foster, B., Murphy, C., Cullor, J., Selsted, M., Mannis, M. and Reid, T.W. The Stimulation
of DNA Synthesis and Cell Growth in Lens Epithelial Cells by Human and Rabbit
Defensins. 8th International Congress of Eye Research, September 4-8, 1988, San
Francisco, California
50.
Mannis, M., Cullor, J., Murphy, C., Selsted, M. and Reid, T. The Use of Defensins for the
Eradication of Ocular Pathogens in Vitro. Annual Meeting of the Ocular Microbiology
and Immunology Groups, October 7, 1988, Las Vegas, Nevada
51.
Iwahashi, C.K. and Reid, T.W. Clones of Lens Epithelial Cells That Show Both Negative
and Positive Stimulation of DNA Synthesis by Dexamethasone. American Society for
Cell Biology, Jan. 29-Feb. 2, 1989, San Francisco, California
52.
Foster, B. and Reid, T.W. Mechanistic Studies on the Aluminum Stimulation of DNA
Synthesis in Late G1/G0. American Society for Cell Biology, Jan. 29-Feb. 2, 1989, San
Francisco, California
53.
Reid, T. and Iwahashi, C. The Modulation of Dexamethasone Inhibition of Lens Epithelial
Cell Growth by Different Growth Factors. ARVO, April 30-May 5, 1989, Sarasota,
Florida
54.
Murphy, C.J., Foster, B., Mannis, M., Cullor, J., Selsted, M. and Reid, T. The Stimulation of
Ocular Cell Growth by Defensins of Human and Rabbit Origin. ARVO, April 30-May 5,
1989, Sarasota, Florida
Ted W. Reid, Ph.D.
Rev
20
12-29-14
55.
Foster, B.A., Murphy, C.J., Mannis, M. and Reid, T.W. The Antimicrobial Peptides Defensins - Stimulate Ocular Cell Growth. Western Eye Research Conference, October 710, 1989, Government Camp, Oregon
56.
Foster, B.A. and Reid, T.W. Modulation of Dexamethasone Mediated Inhibition of EGFStimulated Cell Growth by Amplification of EGF-Receptors in NIH 3T3 Cells. UCLA
Molecular Biology Symposium, January 29-February 2, 1990, Keystone, Colorado
57.
Reid, T.W., Murphy, C.J., Iwahashi, C., Malfroy, B. and Mannis, M.J. The Stimulation of
DNA Synthesis in Epithelial Cells by Substance P and CGRP. ARVO, April 28-May 4,
1990, Sarasota, Florida
58.
Murphy, C.J., Mannis, M.J., Malfroy, B. and Reid, T.W. Neuropeptide Depletion Impairs
Corneal Epithelial Wound Healing. ARVO, April 28-May 4, 1990, Sarasota, Florida
59.
Mannis, M.J., Murphy, C., Reid, T.W. and Iwahashi, C. The role of Neuropeptides in the
Genesis and Treatment of Corneal Ulcers. Castroviejo Cornea Society, October 27, 1990,
Atlanta, GA
60.
Villablanca, A.C. and Reid, T.W. Substance P Stimulates Proliferation of Bovine Aortic
Endothelial Cells in Serum-Free Culture. UCLA Molecular Biology Symposium, April 1April 7, 1991, Keystone, Colorado
61.
Plotnik, R.D., Mannis, M.J., Schwab, I.R., Cullor, J., Jan, B., Iwahashi, C., Reid, T.W. and
Murphy, C.J. Gel Cyanoacrylate: Corneal Bonding Characteristics, Cell Toxicity, and
Antimicrobial Properties. ARVO, April 28-May 4, 1991, Sarasota, Florida
62.
Mannis, M.J., Schwab, I.R., Dries, D., Cullor, J., Smith, W., Reid, T.W. and Murphy, C.J.
Defensins as a preservative in Corneal Storage Medium. ARVO, April 28-May 4, 1991,
Sarasota, Florida
63.
Murphy, C.J., Mannis, M.J. and Reid, T.W. Enkephalinase Decreases Lens Regeneration in
Aphakic Rabbits. ARVO, April 28-May 4, 1991, Sarasota, Florida
64.
Reid, T.W., Murphy, C.J., Iwahashi, C.K. and Mannis, M.J. Mechanism of Stimulation of
DNA Synthesis and Cell Growth in Epithelial Cells by Substance P. ARVO, April 28May 4, 1991, Sarasota, Florida
65.
Teplitz, R.L., Roth, A., Albert, D., Reid, T.W., Schultz, D. and Butler, B.B. Is
retinoblastoma heterogeneity multigenic? 8th International Congress of Human
Genetics. October 6-11, 1991, Washington D.C.
66.
Nishida, T., Nakamura, M., Mishima, H., Otori, T., Reid, T.W., Murphy, C.J. and Mannis,
M.J. Synergistic Effects of Substance P with Epidermal Growth Factor and Insulin-Like
Growth Factor on Corneal Epithelial Migration in Culture. ARVO, April 28-May 4, 1992,
Sarasota, Florida
67.
Villablanca, A.C. and Reid, T.W. Nicotine effects on endothelial cell growth.
Molecular Biology Symposium, January 13-19, 1992, Keystone, Colorado
UCLA
Ted W. Reid, Ph.D.
Rev
21
12-29-14
68.
Reid, T.W., Murphy, C.J. and Crosson, C.E. Mechanistic Studies on the Stimulation of DNA
Synthesis and Cell Growth in Epithelial Cells by Substance P
ARVO, April 28-May 4, 1992, Sarasota, Florida
69.
Murphy, C.J., Jaynes, J., Iwahashi, C., Cullor, J., Reid, T.W., Mannis, M.J. and Schwab, I.R.
The Modulation of Ocular Cell Growth by Cecropins. ARVO, April 28-May 4, 1992,
Sarasota, Florida
70.
Walkup, R.D., Birney, D.M., Reid, T.W., Crosson, C.E., Cole, D.C. and Wagenseller, E.P. The bisphenylalanine moiety of substance P: Evaluation of synthetic analogues for the modulation of
epithelial cell growth. Keystone Symposia, Mar 8-14, 1993, Taos, New Mexico.
71.
Dushku, N., Tyler, N. and Reid, T.W. Immunohistochemical Evidence that Pterygia Arise from
Altered Limbal Epithelial Basil Stem Cells. ARVO, May 2-7, 1993, Sarasota, Florida
72.
Reid, T.W., Murphy, C.J., Crosson, C.E. and Johnson, M. The Substance P Receptor for Cell
Growth is not the same as the One for Smooth Muscle Contraction. ARVO, May 2-7, 1993,
Sarasota, Florida
73.
Birney, D.M., Cole, D.C., Kahl, B.F., Reid, T.W., Wagenseller, E.P. and Walkup, R.D. Substance
P bearing phenylalanine analogs: The effects of subtle spatial differences upon substance P's
ability to stimulate smooth muscle contraction and epithelial cell growth. Gordon Conference:
Biopolymers, February 14-18, 1994, Ventura, CA.
74.
Walkup, R.D., Birney, D.M., Cole, D.C., Kahl, B.F., Reid, T.W. and Wagenseller, E.P. Substance
P bearing phenylalanine analogs: The effects of subtle spatial differences upon substance P's
ability to stimulate smooth muscle contraction and epithelial cell growth. American Chemical
Society, March 13-17, 1994, San Diego, California
75.
Nakamura, M., Nishida, T., Reid, T.W. and Murphy, C.J. Substance P (SP) enhances EGF
stimulated corneal epithelial cell migration, however this action of SP is not mediated by the
NK-1 or NK-2 receptors. ARVO, May 1-6, 1994, Sarasota, Florida
76.
Reid, T.W., Kahl, B.F., Crosson, C.E., Walkup, R.D., Cole, D.C., Birney, D.M., Wagenseller, P.E.
and Murphy, C. Substance P (SP): Effects of subtle spatial changes in the phenylalanine residue
on SP's ability to stimulate iris smooth muscle contraction. ARVO, May 1-6, 1994, Sarasota,
Florida
77.
Dushku, N. and Reid, T.W. Immunohistochemical evidence that pterygia originate from p53
expressing transformed limbal epithelial basal stem cells. ARVO, May 1-6, 1994, Sarasota,
Florida
78.
Reid, T.W., Kahl, B.F., Birney, D.M., Walkup, R.D., Ren, K., Cole, D.C. and Neff, B.W. Methyl
substitution on the -carbon of the phenylalanines of substance P (SP) to probe the nature of SP's
interaction with its receptor. American Society for Cell Biology, December, 1994, San
Francisco California.
79.
Chen, J.J., Reid, T.W., Boylan, L.M. and Spallholz, J.E. Evaluation of selenite toxicity on two
lines of human ovarian tumor cells NIH: OVCAR-3 and A2780 cells. FASEB Experimental
Biology April 9-13, 1995, Atlanta, Georgia
Ted W. Reid, Ph.D.
Rev
22
12-29-14
80.
Boylan, L.M., Spallholz, J.E., Morales, J. and Reid, T.W. The use of selenium covalently attached
to a cellulose sponge to inactivate growth factors as measured by the stimulation of epithelial cell
growth. FASEB Experimental Biology April 9-13, 1995, Atlanta, Georgia
81.
Morales, J., Boylan, L., Spallholz, J., Murphy, C., Dubielzig, R. and Reid, T. Selenium used to
modulate wound healing after glaucoma filtration surgery in the rabbit model. ARVO, May 1419, 1995, Ft. Lauderdale, Florida.
82.
Kahl, B., Birney, D., Walkup, R., Ren, K., Cole, D., Neff, B. and Reid, T. The rabbit ocular
substance P (SP) receptor: The use of methyl substitution on the -carbon of the phenylalanines
of SP analogs to probe the nature of the SP/receptor interaction. ARVO, May 14-19, 1995, Ft.
Lauderdale, Florida.
83.
Murphy, C., Russell, P. and Reid, T. Substance P accelerates corneal epithelial wound healing of
galactose rats. ARVO, May 14-19, 1995, Ft. Lauderdale, Florida.
84.
Dushku, N. and Reid, T. Immunohistochemical evidence that pterygia originate from Rb and
TGF expressing, p53 transformed limbal basal stem cells. ARVO, May 14-19, 1995, Ft.
Lauderdale, Florida.
85.
Reid, T., Kahl, B., Birney, D., Walkup, R., and Ren, K. The use of Methyl Substitution of the carbon of the phenylalanines of substance P (SP) analogs to Probe the Nature of the SP Receptor
Subtypes. Tachykinins '95, October 16-18, 1995, Florence, Italy.
86.
Jones, J., Chen, L., Straub, M., Butterick, C., Morrow, K.J., Reid, T., and Spallholz, J. Conjugation
of Selenium to a Monoclonal Prostate Tumor Antibody 7E11:Superoxide Generation, ELISA
Assay and In Vitro Cytotoxicity. Keystone, January 29-Feb 1, 1996, Taos, New Mexico.
87.
Kahl, B.F., Reid, T.W., Walkup, R.D., Cole, D.C., Birney, D.M., Ren, K. The use of methyl
substitution of the -carbon of the phenylalanines of substance P (SP) analogs to probe the nature
of the SP receptor subtypes in ocular tissue. Western Eye Research Conference, February 22-25,
1966, Boerne, Texas.
88.
Griffith, S., McCartney, D., Steward, K., Murphy C., Mannis M., and Reid, T. Effects of the Bovine
Neutrophil Antibiotic Dodeca-Peptide (BNP-1) on the Growth of Human Corneal Endothelial
Cells in Optisol and Tissue Culture Media. Eye Bank Association of Texas Meeting, March 2,
1996, Austin, Texas.
89.
Nakamura, M., Nishida, T., Ofuji, K., Reid, T., Murphy, C., and Mannis, M., Synergistic Effect of
Substance P with Epidermal Growth Factor on Corneal Epithelial Migration. World Congress in
Cornea. April 18-19, 1996, Ft. Lauderdale, Florida.
90.
Straub, M.J., Chen, L., Butterick, C., Morrow, K.J., Jones, J.A., Reid, T.W. and Spallholz, J.
Selenium-conjugate induced prostate cancer cell cytotoxicity. 87th Annual Meeting of American
Association for Cancer Research, April 20-24, 1996, Washington, D.C.
91.
Reid, T.W. The role of basement membrane in ocular epithelial cell p53 expression and limbal stem
cell migration. 2nd Ocular Surface and Tear Workshop, April 20, 1996, Miami, Florida.
Ted W. Reid, Ph.D.
Rev
23
12-29-14
92.
Reid, T.W., Saban, R., Bjorling, E.E., Kahl, B.F., Birney, D.M., Walkup, R.D., Ren, K. and Murphy,
C.J. The use of methyl substitution of the -carbon of the phenylalanines of substance P (SP)
analogs to probe the nature of the SP/receptor interaction. ARVO, April 21-26, 1996, Ft.
Lauderdale, Florida.
93.
Griffith, S.A., McCartney, D.L., Murphy, C.J., Mannis, M.J. and Reid, T.W. Effect of the bovine
neutrophil antibiotic dodeca-peptide (BNP-1) on the growth of human corneal endothelial cells in
Optisol and tissue culture media. ARVO, April 21-26, 1996, Ft. Lauderdale, Florida.
94.
Dushku, N. and Reid, T.W. Basement membrane dependent P53 expression in limbal-corneal
epithelia of pingueculae, pterygia, limbal tumors and normal eyes. ARVO, April 21-26, 1996, Ft.
Lauderdale, Florida.
95.
Lee, C.H., Nelson, M., Barney, N.P., Brightbill, F.S., Araki-Sasaki, K., Reid, T. and Murphy, C.J.
Migration and proliferation characteristics of SV-40 transformed human corneal epithelial cells in
response to neuropeptides. ARVO, April 21-26, 1996, Ft. Lauderdale, Florida.
96.
Reid, T.W., Kahl, B.F., Walkup, R.D., Birney, D.M., Ren, K. Methyl substitution of the carbon on the phenylalanines of substance P (SP) as probes to the nature of the SP
receptor subtypes. Protein Society, August 3-7, 1996, San Jose, California.
97.
Spallholz, J.E., Chen, L., Reid, T., Jones, J., Straub, M., Morrow, J. and Butterick, C. Covalent free
radical chemistry of selenium immuno-conjugates and their potentially useful pharmaceutical
applications. Sixth International Symposium on Selenium in Biology and Medicine, August 1822, 1996, Beijing, China.
98.
Reid, T.W., Boylan, L.M., Spallholz, J.E., Graham, S., Murphy, C.J., Dubielzig, R.R., Shetlar, M.
and Morales, J. The ability of selenium covalently attached to an inert cellulose matrix to
modulate fibrosis by growth factor inactivation. Sixth International Symposium on Selenium in
Biology and Medicine, August 18-22, 1996, Beijing, China.
99.
Dushku, N. and Reid, T.W. Basement membrane dependent p53 and Rb expression in limbal-corneal
epithelia of pingueculae, pterygia, limbal tumors and normal eyes. American Society for Cell
Biology, December 7-11, 1996, San Francisco, California.
100.
Spallholz, J.E., Boylan, M., Reid, T.W. and Chen, L. In vitro and in vivo cytotoxicity of a B72.3
Mab-Se immunoconjugate against LS174T Colon Tumor Cells. FASEB Experimental Biology
April 6-9, 1997, New Orleans, Louisiana.
101.
Chen, L., Boylan, M., Reid, T.W. and Spallholz, J.E. Cytotoxicity of an internalizing 7E11-C5 MabSe immunoconjugate against DU145 prostate tumor cells. FASEB Experimental Biology April 6-9,
1997, New Orleans, Louisiana.
102.
Reid, T.W., Boylan, L.M., Spallholz, J.E. and Morales, J. Selenium covalently attached to an inert
cellulose matrix modulates cellular growth in vitro by growth factor inactivation. FASEB
Experimental Biology April 6-9, 1997, New Orleans, Louisiana.
103.
Dushku, N., Albert, D.M. and Reid, T.W. Classification of P53 Expression in Limbal Cells of
Pingueculae, Pterygia, and Premalignant and Malignant Limbal Tumors. ARVO, May 11-16, 1997,
Ft. Lauderdale, Florida.
Ted W. Reid, Ph.D.
Rev
24
12-29-14
104.
Spallholz, J.E., Reid, T.W., and, Richard, W., Selenium Immunoconjugate Therapeutics. IBC
Symposium on Antibody-Based Therapeutics, June 5-6, 1997, Boston, Massachusetts.
105.
Reid, T.W., Boylan, L.M., Spallholz, J.E. and Morales, J. Modulation of cellular growth in vitro by
growth factor inactivation with selenium covalently attached to an inert cellulose matrix.
International Congress of Biochemistry and Molecular Biology, August 24-29, 1997, San
Francisco, California.
106.
Reid, T. W., Smith-Morrow, J. A., Lamberts, D.W., Nishida, T., Murphy, C. J. and Spallholz, J. E.
Substance P Mediates Corneal Wound Healing. Keystone Symposia, January 10-15, 1998,
Keystone, Colorado.
107.
Steward, K., Johnson, M., McCartney, D.L., Murphy, C.J., Mannis, M.J. and Reid, T.W., Effect Of
The Bovine Neutrophil Antibiotic Dodeca-Peptide (Bnp-1) On The Viability Of Human Corneal
Endothelial Cells Stored In Optisol. Eye Bank Association of Texas, February 28, 1998, Dallas,
Texas.
108.
Spallholz, J.E., Shriver, B.J. and Reid, T.W., Dimethyldiselenide generates superoxide in an in vitro
chemiluminescence assay in the presence of glutathione. Experimental Biology 98, April 18-22,
1998, San Francisco, California.
109.
Zang, A., Penturf, M., O'Bannon, S., Griswald, J., Reid, T.W., Spallholz, J. and Boylan, L.M.,
Topical application of selenocystamine does not promote wound healing in the rat. Experimental
Biology 98, April 18-22, 1998, San Francisco, California.
110.
M. Shami, J. Wong, C.J. Murphy, R.R. Dubielzig and T.W. Reid The Use Of Antisense DNA
Against The Receptors For Platelet Derived Growth Factor, Fibroblast Growth Factor, And
Phosphoinositol-3-Kinase In Vitro And To Block PVR In A Rabbit Model Using Human Pigment
Epithelial Cells. ARVO, May 10-15, 1998, Ft. Lauderdale, Florida.
111.
T.W. Reid, K. Steward, M. Johnson, D.L. McCartney, M.J. Mannis and C.J. Murphy Studies on the
effect of the bovine neutrophil antibiotic dodeca-peptide (bnp-1) on the viability of human corneal
endothelial cells stored in Optisol. ARVO, May 10-15, 1998, Ft. Lauderdale, Florida.
112.
Nicholas Dushku, Daniel M. Albert and Ted W. Reid The Use Of PCR To Test For Human
Papillomavirus DNA In P53 Expressing Limbal Stem Cells Of Pinguecula, Pterygia And Limbal
Tumors. ARVO, May 10-15, 1998, Ft. Lauderdale, Florida.
113.
Marfurt, C.J., Murphy, C.J., Jones, M.A., Reid, T.W. and McDermott, A., Peptidergic innervation of
the normal dog cornea and of dog corneas with spontaneous chronic epithelial erosions. ARVO,
May 10-15, 1998, Ft. Lauderdale, Florida.
114.
Reid, T.W., Spallholz, J.E. and Shriver B. The Use of Selenium Covalently attached to a Cellulose
Sponge to Modulate Cellular Growth. Surfaces in Biomaterials ’98, September 2-5, 1998, Tucson,
Arizona.
115.
Morrow, K.J., Spallholz, J.E., and Reid, T.W., Selenium Conjugates of an Immunoglobulin and a
Steroid for use as Prostate Cancer Therapeutics. IBC Symposium on Prostate Cancer: Advances
in Diagnostics and Therapeutic Development, November 19-20, 1998, Amelia Island, Florida.
Ted W. Reid, Ph.D.
Rev
25
12-29-14
116.
Reid, T.W. and P. Tran, Substance P is synergistic with insulin and IGF-1 in the stimulation of
corneal epithelial cell migration. American Society for Cell Biology, December 12-16, 1998, San
Francisco, California.
117.
Reid, T.W., Spallholz, J.E., Xiang, L. and Morales, J., Selenium Covalently Bound To The Surface
Of A Cellulose Sponge Used To Modulate Wound Healing After Glaucoma Filtration Surgery,
Society for Biomaterials, April 28-May 2, 1999, Providence, Rhode Island.
118.
Dushku, N., and Reid, T.W., Abnormal Hras Suppression and Activation in the Altered Limbal Stem
Cells (Pterygium Cells) of Pterygia, ARVO, May 9-14, 1999, Ft. Lauderdale, Florida.
119.
Reid, T.W., Tran, P. Nishida, T. and Murphy C. J., The Stimulation of Rabbit Corneal Epithelial
Cell Migration in Culture by Substance P, is Synergistic with Insulin and IGF-1, ARVO, May 914, 1999, Ft. Lauderdale, Florida.
120.
Murphy C. J., Campbell and Reid, T.W., Treatment of Chronic Non-Septic Corneal Epithelial
Defects in Dogs Using Topical Substance P and IGF-1, ARVO, May 9-14, 1999, Ft. Lauderdale,
Florida.
121.
Bentley, E., Abrams, G.A., Covitz, D., Cook, C.S., Reid, T.W., and Murphy C. J., Morphology of
Chronic Non-Septic Corneal Epithelial Defects in Dogs, ARVO, May 9-14, 1999, Ft. Lauderdale,
Florida.
122.
Reid, T.W. and Spallholz J., Selenium Covalently Attached to Biomaterials Blocks Biofilm
Formation, 11th Symposium on the Material Science and Chemistry of Contact Lenses, November
10-12, 1999, New Orleans, LA.
123.
Dushku, N., M.K. John, G.S. Schultz, and T.W. Reid, Pterygia Pathogenesis: Corneal invasion by
matrix metalloproteinase (MMP) expressing altered limbal basal Stem cells and activation of
fibroblasts. , ARVO, April 30-May 5, 2000, Ft. Lauderdale, Florida.
124.
Campbell, S.F., Reid, T.W., and Murphy, C.J., The effects of growth factors, neuropeptides and
neurotransmitters on NGF content in SV-40 transformed human corneal epithelial cells. ARVO,
April 30-May 5, 2000, Ft. Lauderdale, Florida.
125.
Murphy, C.J., Campbell, S.F. and Reid, T.W. Modulation of SV-40 transformed human corneal
epithelial cell proliferation, migration, and adhesion by nerve growth factor. ARVO, April 30May 5, 2000, Ft. Lauderdale, Florida.
126.
Reid, T.W., N. Dushku, M.K. John, and G.S. Schultz, The role of matrix metalloproteinases (MMP)
in corneal invasion by altered limbal basal stem cells and the activation of fibroblasts of pterygia.
American Society for Cell Biology, December 9-13, 2000, San Francisco, California.
127.
Murphy, C. J., Marfurt, C., and Reid, T.W., SP and Chronic non-healing Epithelial Defects in Dogs,
ICER, October 15-20, 2000 Santa Fe, NM.
128.
Reid, T.W. Selenium covalently bound to surfaces of different materials can modulate cellular
attachment by the delivery of superoxide radicals to the surface of the material. Surfaces in
Biomaterials, August 30-September 2, 2000 Scottsdale, AZ.
Ted W. Reid, Ph.D.
Rev
26
12-29-14
129.
Morrow, K.J., Spallholz, J.E. and Reid T.W, Selenium Conjugates of an Immunoglobulin and a
Steroid for Use as Prostate Cancer Therapeutics, 7th International Symposium on Selenium in
Biology and Medicine, October 1-5, 2000 Venice Italy
130.
Spallholz, J.E., Shriver, B., Boylan, L.M. and Reid T.W, Selenium: preventing and treating cancer
in the new millennium. 7th International Symposium on Selenium in Biology and Medicine,
October 1-5, 2000 Venice Italy
131.
Reid, T.W., Dushku, N., John, M.K. and Schultz, G.S. The role of matrix metalloproteinase (MMP)
in corneal invasion by altered limbal basal stem cells and the activation of fibroblasts of pterygia.
American Society for Cell Biology, December 9-13, 2000, San Francisco, California.
132.
Reid, T.W. and Spallholz, J.E. The covalent attachment of selenium to the surface of different
ocular materials can modulate cellular attachment by the delivery of superoxide radicals to the
surface of the material. Society for Biomaterials, April 24-29, 2001 Saint Paul, MN.
133.
Reid, T.W., Schneider, B. G. and Dushku, N. Accumulation of p53 protein in isolated pterygial
epithelium is not accompanied by TP53 gene mutation. ARVO, April 30-May 5, 2001, Ft.
Lauderdale, Florida.
134.
Reid, T.W. and Spallholz, J.E. Organo-selenium attached to a matrix delivers superoxide radicals.
The 6th US-Japan Symposium on Drug Delivery Systems December 16-21, 2001 Maui, HI
135.
Mathews, S.M., Spallholz, J.E. Dubielzig, R.R., Grimson, M.J. and Reid, T.W. The Efficacy of an
Organo-Selenium Coating on Silicone Hydrogel Contact Lenses. ARVO. May 5-10, 2002, Ft.
Lauderdale, Florida.
136.
Reid, T.W., Tran P., and Fralick, J.A. Counter Terrorism Measures to Combat Yersinia pestis with
Selenium. 2002 Joint Service Scientific Conference on Chemical & Biological Defense Research,
November 19-21, 2002, Hunt Valley MD.
137.
Reid, T.W., Spallholz, J.E. Dubielzig, R.R., Grimson, M.J. and Mathews, S.M. Modulation
of Bacterial Attachment to the Surface of Silicone Contact Lenses as a Result of the
Formation of Superoxide Radicals on the Surface of the Polymer by Covalently Bound
Organo-Selenium. American Chemical Society 224th National Meeting, August 18-22,
2002, Boston, MA.
138.
Kerr, T., Gray, T. and Reid, T.W. Interaction between Substance P, EGF, FGF and IGF-1 on
the Release of Internal Calcium in Cells in Culture, American Society for Cell Biology,
December 14-18, 2002, San Francisco, California.
139.
Reid, T.W., Tran P., Spallholz J., and Fralick, J., Counter Terrorism Measures to Combat
Yersinia pestis with Selenium. Annual Meeting of the Consortium of Biological Defense
Researchers, April 28-30, 2003, Lubbock, TX.
140.
Reid, T.W., John, M., Dushku, N., Pearson, K.E., Stephan, D.A., Schultz, G. and Carper, D.,
Microarray Gene Expression in Pterygia, ARVO, May 4-9, 2003, Ft. Lauderdale, Florida. Invest.
Ophthalmol Vis Sci. 2003;4:E1327 www.iovs.org
Ted W. Reid, Ph.D.
Rev
27
12-29-14
141.
Reid, T.W., Tran P., Spallholz J., and Fralick, J. The use of a selenium-peptide to specifically
inactivate Yersinia pestis. 2003 Joint Service Scientific Conference on Chemical & Biological
Defense Research, November 17-20, 2003, Hunt Valley MD.
142.
Kerr, T., Gray, T., McAnulty, J., Murphy, C. and Reid, T. Use of the Defensin Peptide BNP-1 and
the Neuropeptide Substance P to Protect Cells under Stress, American Society for Cell Biology,
December 13-17, 2003, San Francisco, California.
143.
Murphy, C.J., Foley, J.D., Waller, K.R., Reid, T.W. and McAnulty, J.F. Trophic Factors Modulate
Signal Transduction Pathways in Cold-Stored Kidney Cells. American Society for Cell Biology,
December 13-17, 2003, San Francisco, California.
144.
Spallholz, J., Gray, T, and Reid, T.w. Se-methylselenocysteine (SeMC) and
Selenomethionine Likely Induce Apoptosis Enzymatically Arresting Human Cancer Cell
Growth In Vitro. NIH meeting on Selenium MD December 17-19, 2003, Bethesda, MD.
145.
C.A. Cox, M.John-Aryankalayil, C.Jaworski, P.Russell, T.Gray, K.Freedman, N.Dushku,
T.W.Reid, D.Carper. Doxycycline inhibits the migration of cultured human pterygial
epithelial cells NIH Research Festival, June 18, 2004
146.
M. John-Aryankalayil, N. Dushku, C.J. Jaworski, C.A.Cox, G. Schultz, K.E. Pearson, D.A.
Stephan, T.W. Reid and D.A. Carper. cDNA Microarray Analysis of Pterygia,
International Congress Of Eye Research, Sydney, Australia, June 24, 2004
147.
T.W. Reid, T.J. Gray, C.J. Murphy, A study of the Substance P Stimulation of Calcium
Release in Human Corneal Epithelial Cells in vitro ARVO, April 25 - 29, 2004, Ft.
Lauderdale, Florida. Invest. Ophthalmol Vis Sci. 2004;45: E-Abstract 2939 www.iovs.org
148.
C.A. Cox, M. John–Aryankalayil, C. Jaworski, P. Russell, T. Gray, K. Freedman, N.
Dushku, T.W. Reid, and D. Carper The Effect of Doxycycline on the Migration of
Pterygial Epithelial Cells grown in Culture Invest. Ophthalmol. Vis. Sci. 2004 45:
E-Abstract 2939 www.iovs.org
149.
T. W. Reid, S. M. Mathews, M.J. Grimson, , J.E. Spallholz, J.E, Selenium Coated Contact Lenses:
Effect Upon Corneal Epithelial Cells and Bacterial Biofilm Attachment 7th World
Biomaterials Congress May 17-21, 2004, Sydney, Australia
150.
E. Bentley, C.F. Marfurt, A.M. McDermott, R.T. Carter, T.W. Reid, C.J. Murphy.
Characterization of unique alterations in the extracellular matrix and
innervation of spontaneous chronic corneal epithelial defects in dogs. 5th World
Cornea Congress, Washington, D.C. April 13-15, 2005.
151.
C.A. Cox, A. Martinez, T.W. Reid, N. Dushku, C. Jaworski, M. John-Aryankalayil, and D.A.
Carper, Doxycycline’s effect on the angiogenic potential of pterygial epithelial cells.
ARVOMay 1-5, 2005, Ft. Lauderdale, Florida. Invest. Ophthalmol Vis Sci. 2005;46: EAbstract 959 www.iovs.org
152.
X. Zhou, P.L. Tran, J. Fralick, and T.W. Reid. Design and structure determination of a
selenium labeled peptide antimicrobial. Protein Society, San Diego CA, June 18-23,
2005.
Ted W. Reid, Ph.D.
Rev
28
12-29-14
153.
Reid, T.W. Be Radical: Factor selenium into your product equation. Bio2005,
Philadelphia, PA June 19-22, 2005.
154.
C.A. Cox, A. Martinez, J. Amaral, R. Salloum, A. Garrick, T.W. Reid,, C. Jaworski, M.
John-Aryankalayil, K.A. Freedman, S.P. Becerra, and D.A. Carper, Doxycycline’s
effectively inhibits Ocular Angiogenesis.. ARVO April 30 - May 4, 2006, Ft. Lauderdale,
Florida. Invest. Ophthalmol Vis Sci. 2006;47: E-Abstract 3758 www.iovs.org
155.
C. Jaworski, M. John-Aryankalayil, M.M. Campos, R.N. Fariss, J. Rowsey, T.W. Reid, N.
Dushku, C.A. Cox, G. Wistow, and D.A. Carper, EST analysis of human pterygium
cDNA library. ARVO April 30 - May 4, 2006, Ft. Lauderdale, Florida. Invest.
Ophthalmol Vis Sci. 2006;47: E-Abstract 4985 www.iovs.org
156.
B. Winsor and T. Reid, “Treatment of Chronic Ulcers with Topical Substance P and Insulinlike-Growth Factor. “Wound Care – Stuttgart 2005, Stuttgart, Ger. September 15-17,
2006.
157.
T. Reid and Julian Spallholz, “The Use of Selenium to Arm Antibodies.” 5Th Antibody
World Summit, San Jose CA, June 12, 2006.
158.
Reid, T. W., Mathews, S.M., Grimson, M.J., Dubielzig, R., Spallholz, J.E. “\Selenium
Coated Contact Lenses: Effect Upon Corneal Epithelial Cells and Bacterial Biofilm
Attachment. Selenium 2006, Madison, Wisconsin July 25, 2006
159.
Reid, T.W. and Julian Spallholz, “ Organo-Selenium covalently bound to the surface of
different materials can modulate cellular attachment by the delivery of superoxide
radicals to the surface of the material. Selenium 2006, Madison, Wisconsin July 26, 2006
160.
Reid, T.W., Murphy, C.J., McAnulty, J.F., and Wolcott, R. The use of substance P in
wound healing and tissue preservation in humans, dogs and rabbits. Neuropeptide
conference, Santorini, Greece, April 19-22, 2007.
161.
Reid, T.W., Murphy, C.J., McAnulty, J.F., and Wolcott, R. The role of substance P in
wound healing and tissue preservation in humans, dogs and rabbits. Gordon Research
Conference, Colby-Sawyer College, June 17-22, 2007.
162.
Tran, P., Fralick, J., Spallholz, J. and Reid, T.W. Use of selenium containing peptides and
phage to selectively kill Yersinia pestis. Texas Tech University Health Sciences
Center Research Day, Lubbock, TX. March 13, 2008.
163.
Tran, H., Gray, T. and Reid, T.W. The ability of substance P to stimulate Calcium release
in a drug delivery system. Howard Hughes Medical Research Institute Research
Days, Lubbock, TX, April 3-4, 2008.
164. Reid, T.W., Tran, P., Mosley, T., Gray, T., Hammond, A., Cortez, J., Shashtri, M., Spallholz,
J. and Hamood, A. Selenium covalently bound to a wound bandage inhibits the
attachment of bacteria. 18th Annual Meeting of the Wound Healing Society SAWC/WHS
Joint Meeting, San Diego CA, April 24-27, 2008.
Ted W. Reid, Ph.D.
Rev
29
12-29-14
165.
Pot, S.A., Chandler, H.L., Colitz, C.M., Bentley, E., Dubielzig, R.R., Mosley, T.S., Reid,
T.W. and Murphy, C.J., Selenium functionalized intraocular lenses inhibit posterior
capsule opacification (PCO) in an ex vivo canine lens capsular bag assay. American
Congress of Veterinary Ophthalmologists, Boston, MA May, 9, 2008.
166.
Pot, S.A., Chandler, H.L., Colitz, C.M., Bentley, E., Dubielzig, R.R., Mosley, T.S., Reid,
T.W. and Murphy, C.J., Inhibition of posterior capsule opacification (PCO) by selenium
functionalization of intraocular lenses in an ex vivo canine lens capsular bag assay.
European Congress of Veterinary Ophthalmologists, Versailles, France June, 23, 2008.
167. Low, T., Jackson, A., Morse, A., Mosley, T., Reid, T.W., Selenium Coating of Water
Distribution Tubing to Inhibit Biofilm, presented at International Conference On
Environmental Systems, June 2008, San Francisco, CA, USA June 2008
168.
Tran, P.L., Hammond, A.A., Mosley, Janette Cortez, J., Gray, T., Colmer-Hamood, J.A.,
Shashtri, M., Spallholz, J.E., Hamood, A.N. and Reid, T.W. Bandages Coated With
Organo-Selenium Inhibit Bacterial Attachment. Society for Biomaterials Meeting,
April, 22-25, 2009.
169.
Reid, T. W. and Wolcott, R., Wound healing in humans and rabbits using substance P.
Wound Healing Society Meeting, Dallas, TX April 26-29, 2009.
170.
Reid, T., Tran, P., Cortez, J., Mosley, T., Shashtri, M., Spallholz, J., Pot, S. and Hamood., A.
Medical Devices Coated with Organo-Selenium Inhibit Bacterial and Cellular
Attachment. International Medical Device Conference, San Jose, CA, September 14-15,
2009.
171.
Yang, W., Bradley, J., McCartney, D., and Reid, T. Growth Factors in Aqueous Humor of
Diabetic and Non-Diabetic Eyes. Amer. Acad of Ophthalmology Meeting, San
Francisco, CA, October, 24-27, 2009.
172.
Cordero, J., Marchbanks, J., Tran, P., Mosley, T., Cortez, J., Timmons, R., Hamood, A., and
Reid, T. An Organo-Selenium Coating of Tympanostomy Tubes Inhibits the
Development of Bacterial Biofilms. Amer Acad of Otolaryngology-Head and Neck
Surgery Meeting, San Diego, CA October 4-7, 2009.
173,
Phat Tran, Thomas Mosley, Mayank Shashtri, Janette Cortez, Abdul Hamood, Ted W. Reid,
Comparison of Bandages Coated With Organo-Selenium or Silver for Their Ability to
Inhibit Bacterial Attachment, Society for Biomaterials, College Station, TX., February
21, 2010
174.
Kakarala, Kokila, Cassie Versteegh Kruczek, Thomas Mosley, Janet Dertien, Abdul
Hamood, and Ted Reid, Selenium cream inhibits biofilm development by bacterial
isolates from burn wounds. TTUHSC Student Research Symposium, February 24, 2010
175.
Campbell, Thomas, Thomas Mosley, Janet Dertien, Ted Reid, John Griswold, Alexander
Horswill, and Abdul Hamood, Selenium inhibits S. aureus biofilms on both surfaces of
hemodialyis catheters. TTUHSC Student Research Symposium, February 24, 2010
176.
Reid, T., What a study of Pterygia teaches us about the Cornea, International Symposium
2010, Yamaguchi, Japan, March 19-23, 2010.
Ted W. Reid, Ph.D.
Rev
30
12-29-14
177.
Mercer, R., and Reid, T.W. The Effect of Selenium Compounds on the Prevention of S.
aureus Biofilm Formation on Contacts Lenses, Association for Research in Vision and
Ophthalmology Meeting, Fort Lauderdale, FL, May 3, 2010
178.
Dhiman Bhattacharyya, Rajendrasing R. Deshmukh, Ted Reid, Thomas Mosley and Richard
B. Timmons. Single-Step Pulsed Plasma Polymerization of Diphenyldiselenide and its
antimicrobial activity. American Chemical Society Meeting, Boston, MA. August 25,
2010.
179.
Reid, T., Tran, P., Mosley, T Tran ,K Jarvis,C. Patel S., Shashtri, M., and Hamood., A.
Biopolymers Containing Selenium: Their Synthesis and Use. International Medical
Device Conference, San Jose, CA, September 28-29, 2010.
180.
Reid, T., Tran, P., Mosley, T., Tran, K., Jarvis., Thomas, J., Hanes, R., Webster, D.,
Hamood, A., Use of Biopolymers Containing Selenium for Biofilm Prevention During
Wound Healing. Wound Healing Society Meeting, Grapevine, TX., April, 16, 2011.
181.
Mitchell, K., Arnett, A.I., Auten, J-C. Hanes, R., Jarvis, C.C., Thomas, J., Hamood, A.,
Dominguez, L., Reid, T.W., The Use Of A Covalent Selenium Coating To Inhibit
Biofilm Formation On A Silicone Scleral Buckle. Association for Research in Vision and
Ophthalmology Meeting, Fort Lauderdale, FL, May 5, 2011.
182.
Scott AM, Haley C, Reid TW, Mosley T, and Hamood A, Selenocystamine inhibits the
growth of opportunistic pathogen P. aeruginosa, and prevents biofilm formation.
Texas, American Association for Microbiology, Dallas November 12, 2011.
183.
Tran P, Reid TW, Lowry N, Tobin E, Aslani A, Colmer-Hamood J, Mosley T, Dertien J,
and Hamood A, Selenium inhibits S. aureus biofilms on hemodialysis catheters in vivo.
Texas, American Association for Microbiology, Dallas November 12, 2011.
184.
Scott AM, Haley C, Reid TW, Mosley T, and Hamood A, Selenocystamine inhibits the
growth of opportunistic pathogen P. aeruginosa, and prevents biofilm formation NCUR
conference Ogdon Utah March 29, 2012.
185.
Wang, JC, Tran, P, Corder, J, Marchbanks, J, Reid, TW, Hamood, A. Selenium coated
Tympanostomy Tubes inhibit Staphylococcus aureus and Haemophilus influenzae
Biofilms: in vitro and in vivo analysis. TTUHSC, March 2012
186.
Enos, T, Tran, P, Reid, TW, Jarvis, C, Mosley, T, Hamood, A, Selenium coated polyester
bandage inhibits the growth of Staphylococcus aureus. TTUHSC, March 2012.
187.
Tran, P., Hamood, A., Mosley, T., Jarvis, C., Thomas, J. Lackey, B., and Reid, T.W. OrganoSelenium Coated Contact Lenses: Effect Upon Bacterial Biofilm Attachment.
Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL,
May 3, 2012.
188.
Mitchell, K., Tran, P., Arnett, A.I., Mosley, T., Hanes, R., Jarvis, C., Hamood, A.,
Dominguez, L., and Reid, T.W. Organo-selenium coatings inhibit multiple species of
Ted W. Reid, Ph.D.
Rev
31
12-29-14
biofilm formation on ophthalmic device material. Association for Research in Vision and
Ophthalmology Meeting, Fort Lauderdale, FL, May 3, 2012.
189.
Reid, T.W., Tran, P., Mosley, T., Jarvis, C., Thomas, J., Tran, K., Hanes, R., Hamood, A.
Antimicrobial properties of selenium covalently incorporated into the polymer of contact
lens case material. Association for Research in Vision and Ophthalmology Meeting, Fort
Lauderdale, FL, May 3, 2012.
190.
Jansen, M.E., Good, D., Sidhu, S., Kaufman, J., Mosley, T., Reid, TW. Testing of a
Selenium (Se) Coated Biomaterial for Use in Glaucoma Surgery. Association for
Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 3, 2012.
191.
Reid, T.W., Tran, P., Mosley, T., Jarvis, C., Nguyen, Hieu, Hanes, R, Hamood, A. A
Selenium Polyurethane Foam Bandage Material for Biofilm Prevention During Wound
Healing. Wound Healing Society Meeting, Atlanta GA., April 19, 2012.
192.
Enos, T, Tran, P, Reid, TW, Jarvis, C, Colmer-Hamood, J, Hamood, A, Selenium coated
polyester bandage inhibits the formation of bacterial biofilms. TTUHSC, March 2013.
193.
Reid, TW, Tran, P, Mosley, T, Jarvis, C, Webster, D, Hanes, R, Hamood, A. Selenium
covalently incorporated into the polymer of contact lens case material inhibits
bacterial biofilm formation. Association for Research in Vision and Ophthalmology
Meeting, Seattle, WA, May 5, 2013
194.
Tran, P, Hamood, A, Webster, D, Jarvis, C, Hanes, R, Reid, TW. Selenium Contact Lens
Hydrogel Polymer: Inhibition of Bacterial Biofilm Formation. Association for Research
in Vision and Ophthalmology Meeting, Seattle, WA, May 5, 2013
195.
Kruczek, C, Kakarala, K, Tran, P, Haley, C, Enos, T, Hamood, A, Reid, TW. Selenium
cream inhibits biofilm development by Gram positive wound pathogens. Wound Healing
Society Meeting, Denver, CO, May 1-5, 2013
196,
Tran, P, Hamood, A, Webster, D, Jarvis, C, Hanes, R, Reid, TW. Selenium Incorporated into
the Polymer of a Contact Lens Hydrogel Polymer Inhibited Bacterial Biofilm Formation.
Materials Today Virtual Conference: Biomaterials, November 19-21, 2013
197.
Reid, TW, Tran, P, Mosley, T, Jarvis, C, Webster, D, Hanes, R, Hamood, A. OrganoSelenium copolymerized into the polypropylene of contact lens case material
inhibits bacterial biofilm formation. Materials Today Virtual Conference:
Biomaterials, November 19-21, 2013
198.
Tran P, Hamood A, de Souza A, Schultz G, Liesenfeld B, Mehta D, and Reid TW, A
polyurethane foam wound dressing containing a bound cationic polymer rapidly kills
planktonic bacteria and prevents biofilm formation in the presence of serum. Wound
Healing Society Meeting, Denver, CO, April 25, 2014
199.
Huynh, D, Tran, P, Pham, P, Hamood, A, Mitchell, K, and Reid, TW. 5% Betadine solution
is not effective in inhibiting the growth of different Gram Negative and Gram Positive
Ted W. Reid, Ph.D.
Rev
32
12-29-14
Pathogens in vitro. Association for Research in Vision and Ophthalmology Meeting,
Orlando, FL, May 5, 2014
200.
Pham, P, Tran, P, Huynh, E, Hamood, A, and Reid TW. Selenium Contact Lens Hydrogel
Polymer: Inhibition of both Gram Negative and Gram Positive Bacterial Biofilm
Formation - A study of different organo-selenium molecules. Association for Research
in Vision and Ophthalmology Meeting, Orlando, FL, May 5, 2014
201.
Eiferman, RA, Tran, PL, Reid, TW, Schultz, GS. Keep the Preservative in the Bottle, Not in
the Eye. Ocular Microbiology and Immunology Group Meeting, Chicago, Ill, October
17, 2014.
Ted W. Reid, Ph.D.
Rev
33
12-29-14
MEETINGS/CONFERENCES/COURSES/PRESENTATIONS:
10/9-12/79
CONFERENCE ON BIOCHEMISTRY OF THE EYE
Oakland University
Rochester, Michigan
Talk by Ted W. Reid: The Characteristics of a Growth Factor Isolated from Human
Retinoblastoma Cells in Tissue Culture.
10/22-23/79
MEETING ON OCULAR TISSUE CULTURE
National Institutes of Health
Bethesda, Maryland
Talk by Ted W. Reid: The Nature of a Newly Discovered Growth Factor from
Retinoblastoma Cells.
11/4-8/79
ANNUAL MEETING OF THE SOCIETY FOR CELL BIOLOGY
Toronto, Canada
Presentation by Sham L. Pahuja, Brian T. Mullins, and Ted W. Reid: Comparison of
Molecular and Kinetic Characteristics of Glutamine Synthetase from Brain Cells and
Retinal Cells.
Presentation by Norman A. Rubin, Andrew Borthwick, J. Albert, D.S. Gregerson, and
Ted W. Reid: Identification and Characterization of a Mitogenic Factor Secreted by
an Established Cell Line of Human Retinoblastoma Maintained in Serum-Free Media.
1/24-25/80
SPECIAL SEMINAR
Ophthalmology Research Center
The Medical College of Wisconsin
Milwaukee, Wisconsin
Talk by Ted W. Reid: Growth Factors and Their Effects on Ocular Cells.
5/8/80
SEMINAR
Imperial Cancer Research Fund Laboratories
London, England
Talk by Ted W. Reid: Ocular Growth Factor Derived from Retinoblastoma Cells
In Culture.
6/5/80
SEMINAR
Ophthalmology Institute of London
Talk by Ted W. Reid: Ocular Growth Factor Derived from Retinoblastoma Cells
in Culture.
10/2/80
FOURTH INTERNATIONAL CONGRESS FOR EYE RESEARCH
Talk by Ted W. Reid: Effect of Retinoblastoma Derived Growth Factors on the
Growth of Lens Cells in Culture
11/10/80
SEMINAR
National Eye Institute/National Institutes of Health
Bethesda, Maryland
Ted W. Reid, Ph.D.
Rev
12-29-14
Talk by Ted W. Reid: Control of Cell Growth by Potassium
11/21/80
SEMINAR
Brooklyn College
Brooklyn, New York
Talk by Ted W. Reid: Control of Cell Growth by Potassium
9/21-24/81
INSERM MEETING
Paris, France
Talk by Ted W. Reid: Effect of Retinoblastoma Derived Growth Factors on
Cells in Culture
6/7-9/82
FOURTEENTH MILES INTERNATIONAL SYMPOSIUM
Baltimore, Maryland
Talk by Ted W. Reid: Cell Fusion
12/15/83
SEMINAR
Revlon Corp. Research Center
Springfield, Virginia
Talk by Ted W. Reid: Mechanism of Action of Retinoblastoma Growth Factor
1/24/84
SEMINAR
Cornell University Medical School
New York, New York
Talk by Ted W. Reid: Genetic Factors in Retinoblastoma Cells
4/19/84
SEMINAR
University of California, Davis Medical Center
Sacramento, California
Talk by Ted W. Reid: Retinoblastoma, Possible Causes
5/15/84
SEMINAR
Yale University Medical School
Human Genetics department
New Haven, Connecticut
Talk by Ted W. Reid: Mechanism of Insulin Stimulation of Cell Growth
7/10/84
SEMINAR
National Institutes of Health, National Eye Institute
Bethesda, Maryland
Talk by Ted W. Reid: Retinoblastoma Derived Growth Factor Stimulation of
Tyrosine Phosphorylation
8/27/84
SEMINAR
University of Illinois, Department of Dairy Science
Urbana, Illinois
Talk by Ted W. Reid: Growth Factors in the Eye
8/30/84
University of Colorado
Department of Chemistry
34
Ted W. Reid, Ph.D.
Rev
12-29-14
Boulder, Colorado
Talk by Ted W. Reid: Mechanism of Ocular Growth Factors
2/4/85
University of California, Davis
Human Anatomy Department
Davis, California
Talk by Ted W. Reid: Growth Factor Control of Cellular Proliferation
4/16/85
University of California, Davis
Neurobiology Study Group
Davis, California
Talk by Ted W. Reid: Retinoblastoma: Growth Control
5/22/85
Imperial Cancer Research Fund
London, England
Talk by Ted W. Reid: Kinetics of Insulin Stimulation of Cell Growth
5/23/85
University of London
Institute of Ophthalmology
London, England
Talk by Ted W. Reid: Oncogenes and Retinoblastoma
11/26/85
Allergan Pharmaceutical Company
Irvine, California
Talk by Ted W. Reid: Inhibition of Unwanted Cell Multiplication in the Eye
11/27/85
Occidental College
Department of Chemistry
Los Angeles, California
Talk by Ted W. Reid: The Nature of Cell Growth Control in the Eye
1/22/86
Louisiana State University
Department of Microbiology and Immunology
New Orleans, Louisiana
Talk by Ted W. Reid: Growth Factors and Control of Cellular Growth
7/17-18/86
Allergan Pharmaceutical Company
Irvine, California
Talks by Ted W. Reid: Growth Factors in the Eye
Wound Healing in the Eye
10/87
Yale University
New Haven, Connecticut
Talk by Ted W. Reid Growth Factors in the Eye
9/89
Western Eye Research Meeting
Timberline, Oregon
35
Ted W. Reid, Ph.D.
Rev
36
12-29-14
Talk by Ted W. Reid:
Ocular Cell Growth
The Antimicrobial Peptides - Defensins - Stimulate
10/89
Chiron
Los Angeles, California
Talk by Ted W. Reid: New Wound Healing Agents for the Eye
10/89
Allergan
Los Angeles, California
Talk by Ted W. Reid: RbDGF as a Wound Healing Agent
12/89
Texas Tech University
Lubbock, Texas
Talk by Ted W. Reid: Growth Factors for Wound Healing in the Eye
12/89
Alcon
Fort Worth, Texas
Talk by Ted W. Reid:
New Wound Healing Agents for the Eye
1/90
UCLA Molecular Biology Symposium
Keystone, Colorado
Talk by Ted W. Reid: Modulation of the Glucocorticoid Receptor by
Growth Factor Receptors
2/90
AMGEN
Thousand Oaks, California
Talk by Ted W. Reid: Converting Growth Factors to Growth Inhibitors
2/90
Triton Inc.
Alameda, California
Talk by Ted W. Reid:
The Ligand for the Erb-B2 Receptor
3/90
University of Arizona
Tucson, Arizona
Talk by Ted W. Reid: Basic Research in Ophthalmology
6/90
Texas Tech University
Lubbock, Texas
Talk by Ted W. Reid: Growth Factors and Wound Healing in the Eye
6/91
Texas Tech University
Lubbock, Texas
Talk by Ted W. Reid: Growth Factors in the Eye
8/90
Contemporary External Disease
Incline Village, NV
Talk by Ted W. Reid: Growth Factors and Wound Healing
6/91
Alcon Pharmaceutical Inc., Fort Worth, TX
Ted W. Reid, Ph.D.
Rev
37
12-29-14
Talk by Ted W. Reid:
in the eye"
"The use of growth factors to treat wound healing problems
10/91
Allergan Inc., Irvine CA
Talk by Ted W. Reid: Use of SP to treat ocular wounds".
9/91
Biochemistry and Molecular Biology
Dept Texas Tech University
Lubbock, Texas
Talk by Ted W. Reid: "Designing growth factor inhibitors"
9-10-92
Area Science Teachers Workshop
Texas Tech University
Lubbock TX
Talk by Ted W. Reid: "How does the eye work?"
2-16-93
Biochemistry and Molecular Biology Dept
Texas Tech University
Lubbock, Texas
Talk by Ted W. Reid: SP as a Growth Factor
12-16-92
Khepri Inc.
Palo Alto, CA
Talk by Ted W. Reid: "Prevention of secondary cataract with enkephalinase"
1-19-93
Khepri Inc.
Palo Alto, CA
Talk by Ted W. Reid: "Enkephalinase binding to IOLs"
4-14-93
Physiology Dept
Texas Tech University
Lubbock, Texas
Talk by Ted W. Reid: Analogs of SP as Growth Factors
4-21-93
Science Spectrum
Talk by Ted W. Reid: "How does the eye work"
3-27-93
Texas Society to Prevent Blindness
Talk by Ted W. Reid: "Prevention of secondary cataract"
7-2-93
Ophthalmology Dept.
Yale University School of Medicine
New Haven CT.
Talk by Ted W. Reid: "Rational drug design"
8-23-93
Texas Biotechnology Corp.
Houston, TX
Ted W. Reid, Ph.D.
Rev
38
12-29-14
Talk by Ted W. Reid: "Rational drug design of neuropeptides involved in wound
healing and cell growth."
1-14-94
Western Eye Research Conference
UCLA conference center, Lake Arrow Head, California
Talk by Ted W. Reid: "Specificity in Target Cell Responses to Growth Factors"
2-23-95
Texas College of Osteopathic Medicine
Fort Worth, TX
Talk by Ted W. Reid: " The mechanism of the interaction of Substance P with its
receptor and its role in disease mechanisms"
4-5-95 to
4-7-95
University of Wisconsin-Madison, Medical School
Madison, Wisc.
Visiting Professorship for Ted W. Reid: " Substance P: Possible Roles in Ocular
Wound Healing and Future Drug Design"; "Pterygia: Cause and Potential Cure";
"Filtering Procedures: A New Technique Involving Selenium"
5-17-95
ARVO Special Symposium on Substance P
Ft. Lauderdale, FL
Talk by Ted Reid on the SP receptor subtypes in the eye.
7-26-95
Television presentation for the California Kaiser Hospital Physicians.
Oakland, CA
Pterygia and Corneal Growths - 1 Hour talk with Dr. Nic Dushku, Moderated by Dr.
H. Minkoff
3-28-96
Questers Discussion Group
Lubbock, TX
Talk by Ted W. Reid: "The ability of sunlight to cause a Pterygium and the role of the
p53 mutation".
4-20-96
University of Miami
Bascon Palmer Eye Institute
Miami, FL
Talk by Ted W. Reid: The role of basement membrane in ocular epithelial cell p53
expression and limbal stem cell migration.
7-1-96
Alcon Pharmaceutical
Fort Worth, TX
Talk by Ted W. Reid: "The ability of selenium coating to block secondary cataract
formation in the eye".
11-30-96
University of Illionis, Chicago
Department of Ophthalmology
Chicago, IL
Talk by Ted W. Reid: “Substance P: Designing a drug for corneal wound healing
based upon it mechanism of action”.
2-3-97
Biotechnology Institute
Ted W. Reid, Ph.D.
Rev
39
12-29-14
Texas Tech University
Lubbock, TX
Talk by Ted W. Reid: " The design of a drug to heal non-healing ulcers.
2-26-97
Department of Biological Sciences
Texas Tech University
Lubbock, TX
Talk by Ted W. Reid: "Substance P: Mechanisms of Control of Epithelial Cell
Growth"
9-22-97
Research to Prevent Blindness Science Writers Conference
Los Angeles, California
Talk by Ted W. Reid: "Shining new light on pterygia"
10-28-97
Protein Design Laboratories, Inc.
Mountain View, California
Talk by Ted W. Reid: "The Use of Selenium Covalently Attached to Antibodies to
Improve Their Ability to Selectively Kill Cells"
11-1-97
Talk to Agricultural Chemistry Class Texas Tech University
Lubbock, TX
Talk by Ted W. Reid: "The design of New Substance P Molecules to Heal Epithelial
Wounds"
11-20-97
Honors Department
Texas Tech University
Lubbock, TX
Talk by Ted W. Reid: "The use of Substance P to Heal Epithelial Wounds"
1-14-98
The Southwest Cancer Center
University Medical Center
Lubbock, TX
Talk by Ted W. Reid: "The use of phage display libraries to design drugs"
1-31-98
Talk to Lubbock Round Table Forum
Lubbock Club
Lubbock, TX
Talk by Ted W. Reid: "New Research Ventures"
5-30-98
Update for the Comprehensive Ophthalmologist
Holiday Inn Civic Center
Lubbock, TX
Talk by Ted W. Reid: "Corneal Albedo"
12-15-98
Talk to Regional American Chemical Society Section
Ted W. Reid, Ph.D.
Rev
40
12-29-14
Amarillo Steak House
Amarillo, TX
Talk by Ted W. Reid: “Designing a drug for corneal wound healing”
4-19-99
Talk to Taps Pharmaceutical
Deerfield IL
Talk by Ted W. Reid: “On the ability of analogs of substance P to yield information
as to the nature of its receptor”
1-26-00
Talk to Ciba Vision
Duluth, Georgia
Talk by Ted W. Reid, “The surface modification of Contact Lenses”.
8-30-00
Talk to Surfaces in Biomaterials 2000
Scottsdale AZ
Talk by Ted W. Reid, “Selenium covalently bound to surfaces of different materials can
modulate cellular attachment by the delivery of superoxide radicals to the surface of the
material.”
11-13-01
Talk to the Microbiology Department of LSU
New Orleans, LA
Talk by Ted W. Reid, "Substance P: Nerves and Wound Healing"
4-26-02
Gifford/Truhlsen Lecturer at the University of Nebraska Ophth. Dept,
Omaha, NB
Talk by Ted W. Reid, “Development of a Treatment for Non-Healing Corneal
Ulcers – Substance P”
4-26-02
Gifford/Truhlsen Lecturer at the University of Nebraska Ophth. Dept,
Omaha, NB
Talk by Ted W. Reid, “Development of a Coating for Glaucoma Valves to Block
Fibrosis”
7-28-02
Talk to the Microbiology Department, Louisiana State University Medical Center, New
Orleans, LA
Talk by Ted. W. Reid: “Healing of corneal ulcers by a neuropeptide”
8-21-02
Talk at the American Chemical Society 224th National Meeting
Boston, MA
Talk by Ted W. Reid, “Modulation of Bacterial Attachment to the Surface of Silicone
Contact Lenses as a Result of the Formation of Superoxide Radicals on the Surface of
the Polymer by Covalently Bound Organo-Selenium.”
10-17-02
Talk to Regional American Chemical Society Section
Amarillo Steak House
Amarillo, TX
Talk by Ted W. Reid: "The use of organo-selenium to modulate bacterial and mammalian
cell growth on a medical device."
Ted W. Reid, Ph.D.
Rev
41
12-29-14
11-18-02
Talk at National Eye Institute
National Institutes of Health
Bethesda, MD
Talk by Ted W. Reid: “Pterygia, it cause and the nature of its pathogenesis”
11-27-02
Talk at the Joint Service Scientific Conference on Chemical And Biological Defense
Research
Hunt Valley Maryland
Talk by Ted W. Reid: “Counter Terrorism Measures to Combat Yersinia Pestis with
Selenium Pharmaceuticals”
4-15-03
Talk to the South Plains Optometric Society
Lubbock, Texas
Talk by Ted W. Reid: “Biofilms and Contact lenses: research on Selenium”
4-30-03
Talk to Annual Meeting of the Consortium of Biological Defense Researchers
Lubbock, Texas
Talk by Ted W. Reid: “Counter Terrorism Measures to Combat Yersinia pestis with
Selenium Pharmaceuticals”
10-25-04
Talk to the Pharmacology Department, Louisiana State University Medical Center, New
Orleans, LA
Talk by Ted. W. Reid: “Design of new antibiotics for specific bacterial killing”
4-13-05
Talk to Lubbock Homebuilders association
Talk by Ted W. Reid: “Designing new drugs”
5-12-05
Talk to Lubbock Regional Bioscience Initiative
Talk by Ted W. Reid: Problems of research development”
6-10-05
Lecture for the Gifford-Truhlsen Day at the University of Nebraska Medical Center, Omaha,
Nebraska.
Talk by Ted W. Reid: Design of a New Type of Antibiotic for Drug Resistant Bacteria
8-26-05
Lecture to the Southwest Cancer Treatment and Research Center Conference
Talk by Ted Reid: "The use of selenium labeled antibodies to kill breast cancer
cells"
6-12-06
Symposium Talk to the Antibody World Summit San Francisco, CA
Talk by Ted Reid: “The use of selenium to arm antibodies”
9-28-06
Lecture to “Biosiris” Gembloux, Belgium
Talk by Ted Reid: The design of new substance P molecules for wound healing of
diabetic wounds.
5-5-07
Talk at the University of Florida – Gainseville
Talk by Ted W. Reid: The use of selenium in the treatment of different ocular
problems.
Ted W. Reid, Ph.D.
Rev
42
12-29-14
4-3-08
Lecture to San Antonio Orthodontists
Talk by Ted W. Reid: The use of selenium to inhibit bacterial attachment to
orthodonic devices.
1-24-09
Lecture at South West Dental Society Meeting, Dallas, Texas
Talk by Ted W. Reid: The prevention of biofilm formation on teeth by selenium
coatings.
1-22-10
Lecture at the Clinical Optometry Update and Review, Lubock Texas
Talk by Ted w. Reid: Modulation of Baterial attachment to contact lenses
9-27-10
Lecture to DSMPTG, Berkeley California
Talk by Ted W. Reid: Selenium containing polymers
9-30-10
Lecture to CooperVision, Pleasanton California
Talk by Ted W. Reid: Selenium coated contact lenses
8-31-11
Lecture to Sybron, Orange California
Talk by Ted W. Reid: The use of selenium to block plaque on teeth
11-2-11
Lecture at TTUHSC, El Paso to Dept. of BioMedical Sciences
Talk by Ted W. Reid: The role of nerves in wound healing
6-22-12
Lecture at Yale University, New Haven Ct., to the Ophthalmology And Visual
Science Department 40 Year Conference
Talk by Ted W. Reid: “The Role of Substance P in Neurotrophic Ulcers”
6-20-14
Lecture at the University of Nanjing, Nanjing, China, Department of Chemistry
Talk by Ted W. Reid: "The use of organo-selenium compounds to produce
antimicrobial devices."
12-22-14
Lecture to Class in Environmental Chemistry at the Muroran Institute of Technology,
Department of Applied Sciences, Muroran, Hokkaido Japan,
Talk by Ted W. Reid: "The Industrial Application of Selenium Chemistry: A Natural
Antimicrobial."
Ted W. Reid, Ph.D.
Rev
43
12-29-14
Lectures and Teaching (2013)
Medical Student Teaching- TTUHSC, MS2 Neuoscience, biochemistry of the eye (1-hour)
November 30, 2013
Resident Teaching – Lectured (3 hours);
Pterygium/pinguecula
1-11-13
Light Damage
2-8-13
Epigenetics and small RNAs: future use in Ophthalmology 9-27-13
Biotechnology Courses
GBTC 6101 Biotechnology Seminar (16 hours)
GBTC 6301 Introduction to Biotechnology (30 hours)
1/14/13 to 4/29/13
1/15/13 to 5/2/13
Undergraduate Teaching – Lectures in Honors Program
Science and Society Honors 3302-H02 (24 hours)
Graduate Student committees:
Anthony Vercillino Ph.D. (2013 - Engineering) "Selenium RO Membranes to block bacterial
Attachment"
Medical Student Research advisor
Eric Huynh - 5% Betadine solution is not effective in inhibiting the growth of different Gram
Negative and Gram Positive Pathogens in vitro
Patrick Pham - Selenium Contact Lens Hydrogel Polymer: Inhibition of both Gram Negative
and Gram Positive Bacterial Biofilm Formation - A Study of Different Organo-Selenium
Molecules
Research Advisor
Quinn Arnett - Effect of Microwave radiation on cellular mutations
Ted W. Reid, Ph.D.
Rev
44
12-29-14
Funding History (2009-2013):
2 R44 DK074187-02
Reid (Co-PI)
07/01/2008 – 08/31/2009
NIH/SIBR, phase II
($1,200,000)
Selenium coated dialysis catheters for reduced biofilm formation
This research is intended to develop a selenium coating for venous catheters and examine the efficacy of the
coating to prevent microbial biofilm development in an animal model.
Role: Co-PI
1 R41 DE018260-01
Reid (PI)
04/01/2008 – 03/31/2009
NIH/SIBR, phase I
Antimicrobial dental devices and waterlines
($120,000)
This research was intended to develop a covalently bound selenium coating for use in dental unit water lines.
Role: PI
Funded by private industry
Reid (PI)
03/01/2007 – 12/31/2010
Auxano Biologics, Inc.
($240,000)
Effect of selenium coated bandages on wound healing
This research was intended to examine the effect of a selenium coating on cotton bandages in preventing
bacterial biofilm development.
Role: PI
1 R41 DE018260-01
Reid (PI)
4/01/2010 – 3/31/2012
NIH/SIBR, phase II
($980,000)
Antimicrobial dental devices and waterlines
This research was intended to develop a covalently bound selenium coating for use in polyurethane dental
unit water lines and surgical waterlines.
Role: PI
1 R41DC)010963-01
Reid (PI)
5/01/2010 – 4/31/2011
NIH/SBIR phase I
($155,000)
Inhibition of Biofilms on Tympanostomy Tubes
This research in intented to develop a covalent bound selenium coating for use in implanted tympanostomy
tubes.
Role: PI
PC100682
Reid (PI)
USAMRMC Phase I
($120,000)
1/17/2011 – 1/16/2012
A cell selective selenoconjugate compound for the treatment of human prostate cancer
This research is for the development of an organo-selenium compound that will selectively kill prostate
epithelial cells in vivo.
Role: PI
NSF 11-691
Reid (Co-PI)
1/12/2012 - 3-11-2013
SBIR Phase I
$149,444
Selenium Biopolymer Spacers to Prevent Biofouling of Reverse Osmosis Modules
Role: Co-PI
NSF 11-691
Reid (co-PI)
3-15-2013 - 2-28-2015
SBIR Phase II
($499,999 ) Sub-award $43,002
Selenium Biopolymer Spacers to Prevent Biofouling of Reverse Osmosis Modules
Ted W. Reid, Ph.D.
Rev
45
12-29-14
Patents:
Title:
Patent Number
Date issue
Method for the preparation of free radical
pharmaceutical, diagnostics and devices using
selenium conjugates.
Filed May 17, 1994
Selenium Carrier Conjugates
5,783,454
July 21,1998
5,994,151
Method for the preparation of free radical
pharmaceutical, diagnostics and devices using
selenium conjugates
Method for the preparation of free radical
pharmaceutical, diagnostics and devices using
selenium conjugates
Method for the preparation of free radical
pharmaceutical, diagnostics and devices using
selenium conjugates
Method for the preparation of free radical
pharmaceutical, diagnostics and devices using
selenium conjugates
Method for the preparation of free radical
pharmaceutical, diagnostics and devices using
selenium conjugates
6,077,714
November
30, 1999
June 20, 2000
Selenium conjugates for the preparation of free
radical pharmaceuticals
European patent in France, Germany, Italy, Spain
and the UK.
Filed on May 12, 1995
Transplant Media
Held by Trophic Solutions LLC
1509 Wood Lane
Madison, WI 53705
Filed on July 27,2001
Method and Compositions using substance P to
promote wound healing Filed on April 27, 1990
(abandoned) Finally filed on July 25, 1994
Inventors: C.J. Murphy, T.W. Reid and M.J.Mannis
Defensin peptide compositions and method of use
Filed on September 6, 1989
Assignee: The Regents of the University of
California, Oakland, California
Transplant Media
European Patent Filed on July 27, 2001
Transplant Media
Canadian Patent Filed July 27, 2001
Transplant Media
Australian Patent Filed July 27, 2001
6,040,197
March 21,
2000
6,033,917
March 7,
2000
6,043,098
March 28,
2000
6,043,099
March 28,
2000
0-804-247
May 7, 2003
6,696,238B2
February 24,
2004
5,616,562
April 1, 1997
5,242,902
September 7,
1993
01957315.3
July 27, 2001
2001/02417331
July 27, 2001
2001/000079073
July 27, 2001
Ted W. Reid, Ph.D.
Rev
46
12-29-14
Methods of using substance P to promote
healing of vascular wounds
8,222,210
July 17, 2012
SELENIUM-BASED BIOCIDAL
FORMULATIONS AND METHODS OF USE THEREOF
2006269657
Australia
8,236,337
5/24/2006
ANTI-MICROBIAL ORTHODONTIC
COMPOSITIONS AND APPLIANCES AND METHODS
OF PRODUCTION AND USE THEREOF
7/13/2009
issued 8/7/12
SELENIUM ATTACHMENT AGENT
Serial Number US
13/704,899
Serial Number
Canada
2838696
SELENIUM ATTACHMENT AGENT
Serial Number EP
11796542.6
4/22/2013
US 2013/0165595
13/762,147
2/7/2013
SELENIUM ATTACHMENT AGENT
SELENIUM-BASED BIOCIDAL
FORMULATIONS AND METHODS OF USE THEREOF
There are 5 US and International patents pending.
12/17/2012
6/17/2011